These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended December 31, 2018
|
|
|
OR
|
|
|
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from__________________ to _______________
|
|
Delaware
|
13-3662955
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
One New York Plaza, New York, New York
|
10004
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Name of each exchange on which registered
|
Class A Common Stock
|
New York Stock Exchange
|
Large accelerated filer
¨
|
|
|
|
Accelerated filer
x
|
Non-accelerated filer
¨
|
|
Smaller reporting company
x
|
||
|
|
|
|
Emerging growth company
¨
|
PART I
|
||
Item 1.
|
||
Item 1A.
|
||
Item 1B.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
PART II
|
||
Item 5.
|
||
Item 6.
|
||
Item 7.
|
||
Item 7A.
|
||
Item 8.
|
||
Item 9.
|
||
Item 9A.
|
||
Item 9B.
|
||
|
|
|
PART III
|
||
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
||
Item 14.
|
||
|
|
|
PART IV
|
||
Item 15.
|
||
|
||
|
||
|
||
|
||
Item 16.
|
|
|
|
|
|
|
Certifications
|
|
|
Exhibits
|
|
|
|
|
•
|
Revlon
- The Revlon segment is comprised of the Company's flagship Revlon brands. Revlon segment products are primarily marketed, distributed and sold in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores in the U.S. and internationally under brands such as
Revlon
in color cosmetics;
Revlon ColorSilk
and
Revlon Professional
in hair color; and
Revlon
in beauty tools.
|
•
|
Elizabeth Arden
- The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally, under brands such as
Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference
and
Skin Illuminating
in the Elizabeth Arden skin care brands; and
Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue
and
Elizabeth Arden Green Tea
in Elizabeth Arden fragrances.
|
•
|
Portfolio
- The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as
Almay
and
SinfulColors
in color cosmetics;
American Crew
in men’s grooming products (which are also sold direct-to-consumer on its americancrew.com website);
CND
in nail polishes, gel nail color and nail enhancements;
Cutex
nail care products;
Pure Ice
in nail polishes; and
Mitchum
in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of
Creme of Nature
hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a body care line under the
Natural Honey
brand and hair color line under the
Llongueras
brand (licensed from a third party) that are both sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.
|
•
|
Fragrances
- The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances, as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as
Juicy Couture
(which are also sold direct-to-consumer on its juicycouturebeauty.com website),
Britney Spears
,
Elizabeth Taylor
,
Curve, John Varvatos
,
Christina Aguilera
,
Giorgio Beverly Hills
,
Ed Hardy
,
Charlie
,
Lucky Brand
,
Paul Sebastian
,
Alfred Sung
,
Jennifer Aniston
,
Mariah Carey
,
Halston
,
Geoffrey Beene
,
La Perla
,
White Shoulders
,
AllSaints
and
Wildfox
.
|
Segment
|
|
COSMETICS
|
|
HAIR
|
|
MEN'S GROOMING
|
|
BEAUTY TOOLS
|
|
FRAGRANCES
|
|
ANTI-PERSPIRANT DEODORANTS
|
|
SKIN CARE / BODY CARE
|
|
|
|
|
|
|
Owned
|
Licensed*
|
|
|
|||||||
Revlon
|
|
Revlon
|
|
Revlon ColorSilk
|
|
|
|
Revlon
|
|
|
|
|
|
|
|
|
|
Revlon ColorStay
|
|
Revlon Professional
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Elizabeth Arden
|
|
Elizabeth Arden
|
|
|
|
|
|
|
|
Elizabeth Arden White Tea
|
|
|
|
|
Visible Difference
|
|
|
|
|
|
|
|
|
|
|
Elizabeth Arden 5th Avenue
|
|
|
|
|
Elizabeth Arden Ceramide
|
|
|
|
|
|
|
|
|
|
|
Elizabeth Arden Green Tea
|
|
|
|
|
Elizabeth Arden Pro
|
|
|
|
|
|
|
|
|
|
|
Elizabeth Arden Red Door
|
|
|
|
|
Prevage
|
|
|
|
|
|
|
|
|
|
|
Elizabeth Arden Always Red
|
|
|
|
|
Skin Illuminating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eight Hour
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPERSTART
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portfolio
|
|
CND
|
|
Creme of Nature
|
|
American Crew
|
|
|
|
|
|
|
Mitchum
|
|
Gatineau
|
|
|
Almay
|
|
Intercosmo
|
|
d:fi
|
|
|
|
|
|
|
|
|
Natural Honey
|
|
|
SinfulColors
|
|
Orofluido
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pure Ice
|
|
Llongueras*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cutex
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fragrances
|
|
|
|
|
|
|
|
|
|
Curve
|
Juicy Couture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Giorgio Beverly Hills
|
Britney Spears
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charlie
|
Elizabeth Taylor
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Halston
|
John Varvatos
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jean Naté
|
Christina Aguilera
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ed Hardy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lucky Brand
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Sebastian
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alfred Sung
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jennifer Aniston
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mariah Carey
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geoffrey Beene
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
La Perla
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
White Shoulders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AllSaints
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wildfox
|
|
|
|
|
•
|
Revlon
: The Company sells a broad range of cosmetics under its flagship
Revlon
brand, which are designed to fulfill consumer wants and needs and are principally priced in the upper range for large volume retailers. The
Revlon
brand is comprised of face makeup, including foundation, powder, blush and concealers; lip makeup, including lipstick, lip gloss and lip liner; eye makeup, including mascaras, eyeliners, eye shadows and brow products; and nail color and nail care lines.
Revlon
products include innovative formulas and attractive colors that appeal to a wide range of consumers. The following are the key brands within the
Revlon
segment:
|
◦
|
Revlon ColorStay
offers consumers a full range of products with long-wearing technology in face, lip, and eye;
|
◦
|
Revlon PhotoReady
products that are offered in face and eye makeup and are designed with innovative photochromatic pigments that bend and reflect light to give a flawless, airbrushed appearance in any light;
|
◦
|
Revlon Age Defying
, which consists of face makeup for women in the over-35 age bracket, with ingredients to help reduce the appearance of fine lines and wrinkles;
|
◦
|
Revlon Ultra HD
, which is a liquid-based lip color offered globally;
|
◦
|
Revlon Super Lustrous
, which is the Company’s flagship wax-based lipcolor and is offered in a wide variety of shades of lipstick and lip gloss; and
|
◦
|
Revlon Mascara
,
which consists of a collection of five mascaras, each with a distinct lash benefit including lash definition, length, volume, magnified volume and length and a high impact all-in-one formula.
|
•
|
Revlon ColorSilk
hair color and hair care products are sold throughout the world in the mass retail channel to large volume retailers and other retailers and provide radiant, long-lasting color that leaves hair nourished, hydrated and ultra-conditioned.
|
•
|
Revlon Professional
includes hair color, hair care and hair treatment products that are distributed exclusively to professional salons, salon professionals and salon distributors and are sold in more than 85 countries.
Revlon Professional
is synonymous with innovation, fashion and technology to service the most creative salon professionals and their clients.
Revlon Professional
salon hair color and hair care products include
Revlonissimo
,
Eksperience
,
Nutri Color Creme
,
UniqOne
and
Revlon Professional Equave
.
|
•
|
American Crew
and
d:fi
: The Company sells men’s shampoos, conditioners, gels and other hair care and men's grooming products for use and sale by professional salons under the
American Crew
brand name. In 2018, the
American
Crew
brand expanded into the prestige channel with the launch of the men's skin and body care line,
American
Crew Acumen
and has introduced the
American Crew TechSeries
product lineup.
American Crew
is the "Official Supplier to Men" of quality grooming products that provide the ultimate usage experience and enhance a man’s personal image.
American Crew
is the leading salon brand created specifically for men and is sold in more than
70
countries (as well as being sold direct-to-consumer on its americancrew.com website). The Company also sells unisex hair products under the
d:fi
brand, which is a value-priced full line of cleansing, conditioning and styling products.
|
•
|
Almay
: The Company’s
Almay
brand consists of hypo-allergenic, dermatologist-tested, fragrance-free cosmetics and skin care products. The
Almay
brand is comprised of face makeup, including foundation, pressed powder, primer and concealer; eye makeup, including eye shadows, mascaras and eyeliners; lip makeup; and makeup removers. Key brands within
Almay
include
Almay Smart Shade
in face;
Almay One Coat
in eye; and
Almay Color + Care
in lip. The
Almay
brand also has a significant makeup remover business under the core
Almay
brand name.
|
•
|
SinfulColors
and
Pure Ice
: In addition to color cosmetics under
SinfulColors
, the Company’s
SinfulColors
and
Pure Ice
brands consist primarily of value-priced nail enamels, available in many bold, vivid and on-trend colors.
|
•
|
Cutex
: The Company's
Cutex
brand consists of a full range of nail care products, including nail polish remover, nail enamels, nail tools and hand and nail care treatments.
|
•
|
CND
: The Company sells nail enhancement systems, nail polishes, gel nail color and treatment products and services for use by the professional nail salon industry under the
CND
brand name. CND-branded professional nail, hand and foot care products are sold in more than
50
countries and the Company recently introduced the
CND
brand into mass retail through CVS stores. CND nail products include:
|
◦
|
CND Shellac
brand 14+ day nail color system, which delivers 14+ days of flawless wear, superior color and mirror shine with zero dry-time and no nail damage. The
CND Shellac
system is a true innovation in chip-free, extended-wear nail color. In 2018, the Company launched
CND Shellac Luxe
, a 2-step gel polish system that is ready to remove in 60 seconds with no nail damage; and
|
◦
|
CND Vinylux
weekly polish, a breakthrough nail polish that uses a patent-pending technology and lasts approximately a week. While ordinary polishes become brittle and deteriorate over time,
CND Vinylux
dries with exposure to natural light to a flawless finish and strengthens its resistance to chips over time.
|
•
|
Mitchum
: The Company's
Mitchum
brand consists of anti-perspirant deodorant products for men and women, with patented ingredients that provide consumers with up to 48 hours of protection.
|
•
|
The Company sells professional hair products under brand names such as
Orofluido
and
Intercosmo
, as well as under the premium priced
Llongueras
brand (licensed from a third party) in Spain. Multi-cultural hair-care products are sold under the
Creme of Nature
brand, primarily in the U.S., to professional salons, large volume retailers and other retailers.
|
•
|
The Company also sells certain skin care products in the U.S. and internationally under various regional brands, including the Company's
Natural Honey
and
Gatineau
brands.
|
•
|
developing quality products with innovative performance features, shades, finishes, components and packaging;
|
•
|
educating consumers, retail customers and salon professionals about the benefits of the Company’s products;
|
•
|
anticipating and responding to changing consumer, retail customer and salon professional demands in a timely manner, including the timing of new product introductions and line extensions;
|
•
|
offering attractively priced products relative to the product benefits provided;
|
•
|
maintaining favorable brand recognition;
|
•
|
generating competitive margins and inventory turns for its customers by providing relevant products and executing effective pricing, incentive and promotional programs and marketing campaigns, as well as social media and influencer marketing activities;
|
•
|
ensuring product availability through effective planning and replenishment collaboration with the Company's customers;
|
•
|
providing strong and effective advertising, marketing, promotion, social media, influencer and merchandising support;
|
•
|
leveraging e-commerce, social media and mobile commerce initiatives and developing an effective omni-channel strategy to optimize the opportunity for consumers to interact with and purchase the Company's products both on-line and in brick and mortar outlets;
|
•
|
maintaining an effective sales force and distributor network; and
|
•
|
obtaining and retaining sufficient retail display and floor space, optimal in-store positioning and effective presentation of its products on-shelf.
|
•
|
limiting the Company’s ability to fund (including by obtaining additional financing) the costs and expenses of executing the Company’s business initiatives, future working capital, capital expenditures, advertising, promotional and/or marketing expenses, new product development costs, purchases and reconfigurations of wall displays, acquisitions, and related integration costs, investments, restructuring programs and other general corporate purposes;
|
•
|
requiring the Company to dedicate a substantial portion of its cash flow from operations to payments on Products Corporation’s indebtedness, thereby reducing the availability of the Company’s cash flow necessary for executing the Company’s business initiatives and for other general corporate purposes;
|
•
|
placing the Company at a competitive disadvantage compared to its competitors that have less debt;
|
•
|
exposing the Company to potential events of default (if not cured or waived) under the financial and operating covenants contained in Products Corporation’s various debt instruments;
|
•
|
limiting the Company’s flexibility in responding to changes in its business and the industry in which it operates; and
|
•
|
making the Company more vulnerable in the event of adverse economic conditions or a downturn in its business.
|
•
|
borrow money;
|
•
|
use assets as security in other borrowings or transactions;
|
•
|
pay dividends on stock or purchase stock;
|
•
|
sell assets and use the proceeds from such sales;
|
•
|
enter into certain transactions with affiliates;
|
•
|
make certain investments;
|
•
|
prepay, redeem or repurchase specified indebtedness; and
|
•
|
permit restrictions on the payment of dividends to Products Corporation by its subsidiaries.
|
•
|
delaying the implementation of or revising certain aspects of the Company's business initiatives;
|
•
|
reducing or delaying purchases of wall displays and/or expenses related to the Company's advertising, promotional and/or marketing activities;
|
•
|
reducing or delaying capital spending;
|
•
|
implementing new restructuring programs;
|
•
|
refinancing Products Corporation's indebtedness;
|
•
|
selling assets or operations;
|
•
|
seeking additional capital contributions and/or loans from MacAndrews & Forbes, the Company's other affiliates and/or third parties;
|
•
|
selling additional Revlon equity or debt securities or Products Corporation's debt securities; and/or
|
•
|
reducing other discretionary spending.
|
•
|
the acceptance of the Company's new product launches by, and sales of such new products to, the Company's customers may not be as high as the Company anticipates;
|
•
|
the Company's marketing, promotional, advertising and/or pricing strategies for its new products may be less effective than planned and may fail to effectively reach the targeted consumer base or engender the desired consumption of the Company's products by consumers;
|
•
|
the rate of purchases by the Company's consumers may not be as high as the Company anticipates;
|
•
|
the Company's wall displays to showcase its new products may fail to achieve their intended effects;
|
•
|
the Company may experience out-of-stocks and/or product returns exceeding its expectations as a result of the Company's new product launches or space reconfigurations or as a result of reductions in retail display space by the Company's customers;
|
•
|
the Company's net sales may also be impacted by inventory management by its customers or changes in pricing, marketing, advertising and/or promotional strategies by its customers;
|
•
|
the Company may incur costs exceeding its expectations as a result of the continued development and launch of new products, including, for example, unanticipated levels of research and development costs, advertising, promotional and/or marketing expenses, sales return expenses or other costs related to launching new products;
|
•
|
the Company may experience a decrease in sales of certain of the Company's existing products as a result of newly-launched products, the impact of which could be exacerbated by shelf space limitations and/or any shelf space loss. (See also Item 1A. Risk Factors - "
Competition in the beauty industry could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.
").
|
•
|
the Company's product pricing strategies for new product launches may not be accepted by its customers and/or its consumers, which may result in the Company's sales being less than it anticipates;
|
•
|
the Company may experience a decrease in sales of certain of the Company's products as a result of counterfeit products and/or products sold outside of their intended territories; and/or
|
•
|
delays or difficulties impacting the Company's ability, or the ability of the Company's suppliers, to timely manufacture, distribute and ship products or raw materials, as the case may be, displays or display walls in connection with launching new products, such as due to inclement weather conditions or other delays or difficulties (such as those discussed under Item 1A. Risk Factors - "
The Company depends on its Oxford, North Carolina facility for production of a substantial portion of its products. Disruptions at this facility and/or at other Company or third-party facilities at which the Company's products are manufactured could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows
"), could have a material adverse effect on the Company's ability to ship and deliver products to meet its customers’ reset deadlines.
|
•
|
developing quality products with innovative performance features, shades, finishes, components and packaging;
|
•
|
educating consumers, retail customers and salon professionals about the benefits of the Company’s products both on-line and in brick and mortar retail outlets;
|
•
|
anticipating and responding to changing consumer, retail customer and salon professional demands in a timely manner, including as to the timing of new product introductions and line extensions;
|
•
|
offering attractively priced products relative to the product benefits provided;
|
•
|
maintaining favorable brand recognition;
|
•
|
generating competitive margins and inventory turns for the Company’s customers by providing relevant products and executing effective pricing, incentive and promotional programs and marketing and advertising campaigns, as well as social media and influencer marketing activities;
|
•
|
ensuring product availability through effective planning and replenishment collaboration with the Company's customers;
|
•
|
providing strong and effective advertising, promotion, marketing, social media, influencer and merchandising support;
|
•
|
leveraging e-commerce, social media and mobile commerce initiatives and developing an effective omni-channel strategy to optimize the opportunity for consumers to interact with and purchase the Company's products both on-line and in brick and mortar retail outlets;
|
•
|
maintaining an effective sales force and distribution network; and
|
•
|
obtaining and retaining sufficient display space, optimal in-store positioning and effective presentation of the Company’s products on-shelf.
|
•
|
the inability to fill customer orders accurately or on a timely basis, or at all;
|
•
|
increased demands on management and staff time to the detriment of other corporate initiatives;
|
•
|
significant capital and operating expenditures;
|
•
|
the inability to process payments to vendors accurately or in a timely manner;
|
•
|
disruption of the Company's internal control structure, as detailed below; and/or
|
•
|
the inability to fulfill federal, state and local reporting and filing requirements in a timely or accurate manner.
|
•
|
develop its fragrance brand portfolio through branding, innovation and execution;
|
•
|
identify and develop new and existing fragrance brands with the potential to become successful global brands;
|
•
|
innovate and develop new fragrance products that are appealing to consumers;
|
•
|
acquire or license additional fragrance brands or secure additional distribution arrangements and the Company's ability to obtain the required financing for these agreements and arrangements;
|
•
|
expand the Company's geographic presence to take advantage of opportunities in developed and emerging regions;
|
•
|
continue to expand the Company's distribution channels within existing geographies to increase trade presence, brand recognition and sales;
|
•
|
expand the Company's trade presence through alternative distribution channels, such as through e-commerce channels;
|
•
|
expand margins through sales growth, the development of higher margin products and overhead and supply chain integration and efficiency initiatives;
|
•
|
effectively manage capital investments and working capital to improve the generation of cash flow; and
|
•
|
execute any acquisitions quickly and efficiently and integrate new businesses successfully.
|
Location
|
|
Segment(s)
|
|
Use
|
|
Approximate Floor Space Sq. Ft.
|
|
Oxford, North Carolina
|
|
Revlon, Portfolio, Elizabeth Arden, Fragrances
|
|
Manufacturing, warehousing, distribution and office
(a)
|
|
1,012,000
|
|
Jacksonville, Florida
|
|
Revlon, Portfolio
|
|
Manufacturing, warehousing, distribution and office
(a) (b)
|
|
731,000
|
|
Salem, Virginia
|
|
Elizabeth Arden
|
|
Warehousing and distribution (leased)
|
|
482,000
|
|
Roanoke, Virginia
|
|
Elizabeth Arden
|
|
Warehousing and distribution (leased)
|
|
399,000
|
|
Mississauga, Canada
|
|
Revlon
|
|
Warehousing, distribution and office (leased)
|
|
195,000
|
|
Tarragona, Spain
|
|
Portfolio, Elizabeth Arden, Fragrances
|
|
Manufacturing, warehousing, distribution and office
|
|
175,000
|
|
Bologna, Italy
|
|
Revlon, Portfolio
|
|
Manufacturing, warehousing, distribution and office
|
|
137,000
|
|
Queretaro, Mexico
|
|
Portfolio, Elizabeth Arden
|
|
Manufacturing, warehousing, distribution and office
|
|
128,000
|
|
Canberra, Australia
|
|
Revlon
|
|
Warehousing and distribution
|
|
125,000
|
|
Edison, New Jersey
|
|
Revlon, Portfolio, Elizabeth Arden
|
|
Research and development and office (leased)
|
|
124,000
|
|
Rietfontein, South Africa
|
|
Revlon
|
|
Warehousing, distribution and office (leased)
|
|
118,000
|
|
Isando, South Africa
|
|
Revlon
|
|
Manufacturing, warehousing, distribution and office
|
|
94,000
|
|
Stone, United Kingdom
|
|
Revlon
|
|
Warehousing and distribution (leased)
|
|
92,000
|
|
(a)
|
Property subject to liens under the 2016 Credit Agreements.
|
(b)
|
Owned: 512,000 Sq. Ft.; Leased: 219,000 Sq. Ft.
|
•
|
$93.9 million
of
lower
gross profit, primarily due to lower net sales;
|
•
|
$34.3 million
of
unfavorable
variance in foreign currency, resulting from
$15.8 million
in foreign currency losses during
2018
, compared to
$18.5 million
in foreign currency gains during
2017
;
|
•
|
a
$26.8 million
increase
in interest expense, primarily due to higher average interest rates and higher borrowings under the 2016 Revolving Credit Facility, as well as higher debt balances resulting from the 2018 Asset-Based Term Facility entered into during the third quarter of 2018;
|
•
|
a
$20.1 million
loss, of which
$18.6 million
was non-cash, related to the write-off of the Company’s minority investment in a licensee after agreeing to wind-down the contract and revert the trademark rights to the Company following a brief transition period; and
|
•
|
a
$7.2 million
increase
in non-cash impairment charges related to goodwill impairment of $
18.0 million
in 2018 related to the Mass Portfolio reporting unit within the Portfolio segment, compared to goodwill impairment of
$10.8
million in
2017
;
|
•
|
a
$39.0 million
decrease
in acquisition and integration costs;
|
•
|
$7.6 million
of
lower
SG&A expenses, primarily driven by lower brand support expenses partially offset by higher costs related to permanent displays;
|
•
|
a
$13.2 million
decrease
in restructuring charges primarily related to lower expenditures under the EA Integration Restructuring Program in 2018 compared to 2017, partially offset by additional restructuring charges related to the 2018 Optimization Program; and
|
•
|
a
$19.6 million
decrease
in the
provision for
income taxes, primarily due to: (i) increased loss from continuing operations before income taxes, partially offset by the reduced benefit attributable to the U.S. tax rate change from 35% to 21% as
|
•
|
Revlon
- The Revlon segment is comprised of the Company's flagship Revlon brands. Revlon segment products are primarily marketed, distributed and sold in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores in the U.S. and internationally under brands such as
Revlon
in color cosmetics;
Revlon ColorSilk
and
Revlon Professional
in hair color; and
Revlon
in beauty tools.
|
•
|
Elizabeth Arden
- The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce business under brands such as
Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference
and
Skin Illuminating
in the Elizabeth Arden skin care brands; and
Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue
and
Elizabeth Arden Green Tea
in Elizabeth Arden fragrances.
|
•
|
Portfolio
- The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as
Almay
and
SinfulColors
in color cosmetics;
American Crew
in men's grooming products (which are also sold direct-to-consumer on its americancrew.com website);
CND
in nail polishes, gel nail color and nail enhancements;
Cutex
in nail care products;
Pure Ice
in nail polishes; and
Mitchum
in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of
Creme of Nature
hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a body care line under the
Natural Honey
brand and hair color line under the
Llongueras
brand (licensed from a third party) that are both sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.
|
•
|
Fragrances
- The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances, as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as
Juicy Couture
(which are also sold direct-to-consumer on its juicycouturebeauty.com website),
Britney Spears
,
Elizabeth Taylor
,
Curve, John Varvatos
,
Christina Aguilera
,
Giorgio Beverly Hills
,
Ed Hardy
,
Charlie
,
Lucky Brand
,
Paul Sebastian
,
Alfred Sung
,
Jennifer Aniston
,
Mariah Carey
,
Halston
,
Geoffrey Beene
,
La Perla
,
White Shoulders
,
AllSaints
and
Wildfox
.
|
|
Net Sales
|
|
Segment Profit
|
||||||||||||||||||||||||||||||||||||||||
|
Year Ended December 31,
|
|
Change
|
|
XFX Change
(a)
|
|
Year Ended December 31,
|
|
Change
|
|
XFX Change
(a)
|
||||||||||||||||||||||||||||||||
|
2018
|
|
2017
|
|
$
|
|
%
|
|
$
|
|
%
|
|
2018
|
|
2017
|
|
$
|
|
%
|
|
$
|
|
%
|
||||||||||||||||||||
Revlon
|
$
|
998.3
|
|
|
$
|
1,089.3
|
|
|
$
|
(91.0
|
)
|
|
(8.4
|
)%
|
|
$
|
(90.1
|
)
|
|
(8.3
|
)%
|
|
$
|
129.6
|
|
|
$
|
180.1
|
|
|
$
|
(50.5
|
)
|
|
(28.0
|
)%
|
|
$
|
(48.6
|
)
|
|
(27.0
|
)%
|
Elizabeth Arden
|
490.2
|
|
|
433.8
|
|
|
56.4
|
|
|
13.0
|
%
|
|
54.1
|
|
|
12.5
|
%
|
|
24.4
|
|
|
6.9
|
|
|
17.5
|
|
|
N.M.
|
|
|
18.4
|
|
|
N.M.
|
|
||||||||
Portfolio
|
564.6
|
|
|
592.5
|
|
|
(27.9
|
)
|
|
(4.7
|
)%
|
|
(26.4
|
)
|
|
(4.5
|
)%
|
|
7.9
|
|
|
8.1
|
|
|
(0.2
|
)
|
|
(2.5
|
)%
|
|
0.1
|
|
|
1.2
|
%
|
||||||||
Fragrances
|
511.4
|
|
|
578.1
|
|
|
(66.7
|
)
|
|
(11.5
|
)%
|
|
(67.6
|
)
|
|
(11.7
|
)%
|
|
76.0
|
|
|
62.2
|
|
|
13.8
|
|
|
22.2
|
%
|
|
14.1
|
|
|
22.7
|
%
|
||||||||
Total
|
$
|
2,564.5
|
|
|
$
|
2,693.7
|
|
|
$
|
(129.2
|
)
|
|
(4.8
|
)%
|
|
$
|
(130.0
|
)
|
|
(4.8
|
)%
|
|
$
|
237.9
|
|
|
$
|
257.3
|
|
|
$
|
(19.4
|
)
|
|
(7.5
|
)%
|
|
$
|
(16.0
|
)
|
|
(6.2
|
)%
|
|
Year Ended December 31,
|
|
Change
|
|
XFX Change
(a)
|
||||||||||||||||
|
2018
|
|
2017
|
|
$
|
|
%
|
|
$
|
|
%
|
||||||||||
Revlon
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
North America
|
$
|
522.3
|
|
|
$
|
581.7
|
|
|
$
|
(59.4
|
)
|
|
(10.2
|
)%
|
|
$
|
(59.3
|
)
|
|
(10.2
|
)%
|
International
|
476.0
|
|
|
507.6
|
|
|
(31.6
|
)
|
|
(6.2
|
)%
|
|
(30.8
|
)
|
|
(6.1
|
)%
|
||||
Elizabeth Arden
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
North America
|
$
|
135.6
|
|
|
$
|
136.5
|
|
|
$
|
(0.9
|
)
|
|
(0.7
|
)%
|
|
$
|
(0.7
|
)
|
|
(0.5
|
)%
|
International
|
354.6
|
|
|
297.3
|
|
|
57.3
|
|
|
19.3
|
%
|
|
54.8
|
|
|
18.4
|
%
|
||||
Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
North America
|
$
|
350.4
|
|
|
$
|
337.9
|
|
|
$
|
12.5
|
|
|
3.7
|
%
|
|
$
|
12.5
|
|
|
3.7
|
%
|
International
|
214.2
|
|
|
254.6
|
|
|
(40.4
|
)
|
|
(15.9
|
)%
|
|
(38.9
|
)
|
|
(15.3
|
)%
|
||||
Fragrances
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
North America
|
$
|
345.9
|
|
|
$
|
377.2
|
|
|
$
|
(31.3
|
)
|
|
(8.3
|
)%
|
|
$
|
(31.2
|
)
|
|
(8.3
|
)%
|
International
|
165.5
|
|
|
200.9
|
|
|
(35.4
|
)
|
|
(17.6
|
)%
|
|
(36.4
|
)
|
|
(18.1
|
)%
|
||||
Total Net Sales
|
$
|
2,564.5
|
|
|
$
|
2,693.7
|
|
|
$
|
(129.2
|
)
|
|
(4.8
|
)%
|
|
$
|
(130.0
|
)
|
|
(4.8
|
)%
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Gross profit
|
$
|
1,447.5
|
|
|
$
|
1,541.4
|
|
|
$
|
(93.9
|
)
|
Percentage of net sales
|
56.4
|
%
|
|
57.2
|
%
|
|
(0.8
|
)%
|
•
|
the impact of additional costs related to the service level disruptions at the Company's Oxford, N.C. manufacturing facility, which decreased gross margin by
1.9
percentage points;
|
•
|
higher sales allowances, which decreased gross margin by
0.8
percentage points; and
|
•
|
higher inventory obsolescence reserves, which decreased gross margin by
0.5
percentage points;
|
•
|
cost reductions associated with insourcing production capabilities, which increased gross margin by
0.8
percentage points;
|
•
|
additional inventory costs in
2017
related to the increase in the fair value of inventory acquired in the Elizabeth Arden Acquisition, that did not recur in
2018
, resulting in an increase in gross margin of
0.6
percentage points; and
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
SG&A expenses
|
$
|
1,460.5
|
|
|
$
|
1,468.1
|
|
|
$
|
(7.6
|
)
|
•
|
a
$46.6 million
decrease in brand support expenses driven partially by the re-phasing of certain marketing initiatives, primarily within the Revlon segment; and
|
•
|
lower general and administrative expenses of approximately
$6 million
, primarily driven by lower incentive compensation expense and lower travel expenses;
|
•
|
higher amortization expense of approximately
$19 million
primarily attributable to the accelerated amortization of the
Pure Ice
intangible assets as a result of the revision of the brand’s intangible assets useful lives following the termination of a business relationship with its principal customer;
|
•
|
higher distribution costs of approximately
$13.5 million
, primarily due to geographic mix; and
|
•
|
higher product display costs of approximately
$11.1 million
, primarily within the Revlon segment.
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Acquisition Costs
|
$
|
—
|
|
|
$
|
3.6
|
|
|
$
|
(3.6
|
)
|
Integration Costs
|
13.9
|
|
|
49.3
|
|
|
(35.4
|
)
|
|||
Total acquisition and integration costs
|
$
|
13.9
|
|
|
$
|
52.9
|
|
|
$
|
(39.0
|
)
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Restructuring charges and other, net
|
$
|
20.2
|
|
|
$
|
33.4
|
|
|
$
|
(13.2
|
)
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Loss on disposal of minority investment
|
$
|
20.1
|
|
|
$
|
—
|
|
|
$
|
20.1
|
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Interest expense
|
$
|
176.6
|
|
|
$
|
149.8
|
|
|
$
|
26.8
|
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Foreign currency losses (gains), net
|
$
|
15.8
|
|
|
$
|
(18.5
|
)
|
|
$
|
34.3
|
|
|
Year Ended December 31,
|
|
|
||||||||
|
2018
|
|
2017
|
|
Change
|
||||||
Provision for income taxes
|
$
|
2.2
|
|
|
$
|
21.8
|
|
|
$
|
(19.6
|
)
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
Net cash used in operating activities
|
$
|
(170.8
|
)
|
|
$
|
(139.3
|
)
|
Net cash used in investing activities
|
(57.2
|
)
|
|
(108.3
|
)
|
||
Net cash provided by financing activities
|
233.1
|
|
|
136.9
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(5.0
|
)
|
|
11.3
|
|
||
Net increase (decrease) in cash, cash equivalents and restricted cash
|
0.1
|
|
|
(99.4
|
)
|
||
Cash, cash equivalents and restricted cash at beginning of period
|
87.4
|
|
|
186.8
|
|
||
Cash, cash equivalents and restricted cash at end of period
|
$
|
87.5
|
|
|
$
|
87.4
|
|
•
|
$178.0 million
of borrowings under the 2016 Revolving Credit Facility; and
|
•
|
$88.9 million
of borrowings under the 2018 Asset-Based Term Facility;
|
•
|
$18.0 million
of repayments under the 2016 Term Loan Facility; and
|
•
|
$9.7 million
of payment of financing costs incurred in connection with the 2018 Asset-Based Term Facility and the Amendment to the 2016 Revolving Credit Facility for
$5.7 million
and
$4.0 million
, respectively.
|
•
|
$157 million of borrowings under the 2016 Revolving Credit Facility;
|
•
|
$18 million of repayments under the 2016 Term Loan Facility.
|
|
Commitment
|
|
Aggregate principal amount outstanding at December 31, 2018
|
|
Availability at December 31, 2018 (a)
|
||||||
Tranche A of the 2016 Revolving Credit Facility
|
$
|
400.0
|
|
|
$
|
293.5
|
|
|
$
|
96.4
|
|
Tranche B of the 2016 Revolving Credit Facility
|
41.5
|
|
|
41.5
|
|
|
N/A
|
|
|||
Total Tranche A& B of the 2016 Revolving Credit Facility
(a)
|
$
|
441.5
|
|
|
$
|
335.0
|
|
|
$
|
96.4
|
|
|
|
Effect of
|
|
Effect of
|
||||||||||||
|
|
25 basis points increase
|
|
25 basis points decrease
|
||||||||||||
|
|
Net periodic benefit costs
|
|
Projected pension benefit obligation
|
|
Net periodic benefit costs
|
|
Projected pension benefit obligation
|
||||||||
Discount rate
|
|
$
|
0.7
|
|
|
$
|
(14.1
|
)
|
|
$
|
0.4
|
|
|
$
|
14.8
|
|
Expected long-term rate of return
|
|
(0.6
|
)
|
|
—
|
|
|
1.7
|
|
|
—
|
|
|
U.S.
Plans
|
|
International
Plans
|
||
Interest cost on projected benefit obligation
|
3.73
|
%
|
|
2.61
|
%
|
Service cost
|
3.85
|
%
|
|
0.87
|
%
|
Interest cost on service cost
|
4.24
|
%
|
|
0.54
|
%
|
(i)
|
the Company did not perform an effective continuous risk assessment process that adequately identified and assessed risks affecting the Company’s internal controls over financial reporting associated with the implementation of its new ERP system in the U.S.;
|
(ii)
|
the Company did not maintain a sufficient number of knowledgeable, trained personnel in the U.S. operations impacted by the ERP system implementation and in various other operations across the Company who understood and were held accountable for their assigned responsibilities for the design, implementation and operation of internal controls over financial reporting
; and
|
(iii)
|
as a result, the Company did not design, implement and consistently operate effective process-level controls to ensure that it appropriately (a) recorded and accounted for inventory, accounts receivable, net sales and cost of goods sold, (b) reconciled balance sheet accounts, (c) reviewed and approved the complete population of manual journal entries and (d) used complete and accurate information in performing manual controls.
|
(i)
|
the Company's future financial performance and/or sales growth;
|
(ii)
|
the effect on sales of decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company’s products as a result of increased competitive activities by the Company’s competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise, changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to the continuing consumption declines in core beauty categories in the mass retail channel in North America; inventory management by the Company's customers; inventory de-stocking by certain retail customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company’s existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company’s expenses, including, without limitation, for pension expense under its benefit plans, acquisition and related integration costs, capital expenditures, costs related to the Company’s synergy and integration programs in connection with the Elizabeth Arden Acquisition, restructuring and severance costs (including, without limitation, those in connection with the EA Integration Restructuring Program and the 2018 Optimization Program), costs related to litigation, advertising, promotional and marketing activities, or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated level of expenses;
|
(iii)
|
the Company's belief that continuing to execute its business initiatives could include taking advantage of additional opportunities to reposition, repackage or reformulate one or more brands or product lines, launching additional new products, acquiring businesses or brands (including through licensing transactions, if any), divesting or discontinuing non-core business lines (which may include exiting certain territories), further refining its approach to retail merchandising and/or taking further actions to optimize its manufacturing, sourcing and organizational size and structure, any of which, the intended purpose would be to create value through improving the Company's financial performance, could result in the Company making investments and/or recognizing charges related to executing against such opportunities, which activities may be funded with operating revenues, cash on hand, funds available under the 2016 Revolving Credit Facility and/or other permitted additional sources of capital, which actions could increase the Company's total debt;
|
(iv)
|
certain beliefs and expectations regarding the Company's progress in resolving customer service level disruptions resulting from the launch of its new ERP system;
|
(v)
|
the effect of restructuring activities, restructuring costs and charges, the timing of restructuring payments and the benefits from such activities, including, without limitation: (A) in connection with implementing the EA Integration Restructuring Program: (1) consolidating offices, eliminating certain duplicative activities and streamlining back-office support (which are designed to reduce the Company's SG&A expenses); and (2) recognizing
$82.2 million
of the EA Integration Restructuring Charges (all of which are expected to be cash payments), consisting of: (x)
$72.2 million
of employee-related costs, including severance, retention and other contractual termination benefits; (y)
$5.1 million
of lease termination costs; and (z)
$4.9 million
of other related charges; (B) the Company's 2018 Optimization Program designed to streamline the Company’s operations, reporting structures and business processes, with the objective of maximizing productivity and improving profitability, cash flows and liquidity, with the major initiatives underlying such program including: (1) optimizing its global supply chain and realizing manufacturing efficiencies and rationalizing its global warehouse network and office locations to drive greater efficiency, lower its cost base and enhance its speed-to-market capabilities for new innovations; (2) enhancing in-market execution and optimizing its commercial and organizational structures to create more efficient global and regional capabilities; and (3) reducing overhead costs and streamlining functions and workflows by leveraging technology and shared services and standardizing and simplifying its business processes, leading to greater agility and faster decision-making; (C) the Company’s expectations regarding the amount and timing of the charges and payments related to the 2018 Optimization Program, including that: (1) it will recognize approximately
$30 million
to
$40 million
of total pre-tax restructuring and related charges, consisting of employee-related costs, such as severance, pension and other termination costs, as well as related third party expenses; (2) it will incur approximately
$10 million
of additional capital expenditures; (3) of the restructuring charges, it recorded pre-tax restructuring charges of
$5.7 million
in 2018, related to the 2018 Optimization Program, with substantially all of the balance to be recognized in 2019; and (4) approximately
85%
of the restructuring charges are to be paid in cash, with approximately
$0.8 million
paid in 2018 and
$25 million
to
$33 million
expected to be paid in 2019, with any remaining balance to be paid in 2020; (D) the Company’s expectation that the actions to be implemented under the 2018 Optimization Program will be substantially completed by December 31, 2019; and (E) the Company’s projection that the 2018 Optimization Program will result in annualized cost reductions in the range of approximately
$125 million
to
$150 million
by the end of 2019;
|
(vi)
|
the Company’s expectation that operating revenues, cash on hand and funds that may be available from time to time for borrowing under Products Corporation's 2016 Revolving Credit Facility and other permitted lines of credit will be sufficient to enable the Company to cover its operating expenses for 2019, including the cash requirements referred to in item (viii) below, and the Company's belief that (a) after giving effect to Amendment No. 2 to the Amended Revolving Credit Facility it continues to have sufficient liquidity to meet its cash needs for at least the next 12 months based upon the cash generated by its operations, cash on hand, availability under the 2016 Revolving Credit Facility and other permitted lines of credit, along with the option to further settle intercompany loans and payables with certain foreign subsidiaries, and that such cash resources will be further enhanced as the Company implements its 2018 Optimization Program and cost reductions generated from other cost control initiatives and (b) restrictions and/or taxes on repatriation of foreign earnings will not have a material effect on the Company's liquidity during such period;
|
(vii)
|
the Company’s expected principal sources of funds, including operating revenues, cash on hand and funds available for borrowing under Products Corporation's 2016 Revolving Credit Facility and other permitted lines of credit, as well as the availability of funds from the Company taking certain measures, including, among other things, reducing discretionary spending and the Company’s expectation to generate additional liquidity from cost reductions resulting from the implementation of the 2018 Optimization Program and from other cost reduction initiatives;
|
(viii)
|
the Company's expected principal uses of funds, including amounts required for payments in connection with the Company’s synergy and integration programs related to the Elizabeth Arden Acquisition (including, without limitation, for the EA Integration Restructuring Program); payments in connection with the Company's purchases of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement benefit plan contributions; payments in connection with the Company's restructuring programs (including, without limitation, those in connection with the EA Integration Restructuring Program and the 2018 Optimization Program); severance not otherwise included in the Company’s restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions, if any); debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade (including, without limitation, that the Company may also, from time-to-time, seek to retire or purchase its outstanding debt obligations and/or equity in open market purchases, block trades, privately negotiated purchase transactions or otherwise and may seek to refinance some or all of its indebtedness based upon market conditions and that any such retirement or purchase of debt and/or equity may be funded with operating cash flows of the business or other sources and will depend upon prevailing market conditions, liquidity requirements, contractual restrictions and other factors, and the amounts involved may be material); and its estimates of the amount and timing of such operating and other expenses;
|
(ix)
|
matters concerning the impact on the Company from changes in interest rates and foreign exchange rates;
|
(x)
|
the Company's expectation to efficiently manage its working capital, including, among other things, initiatives intended to optimize inventory levels over time; centralized procurement to secure discounts and efficiencies; prudent management of trade receivables, accounts payable and controls on general and administrative spending; the effects of service level disruptions to the Company’s manufacturing operations as a result of the launch of its new ERP system and actions that the Company is taking to implement a service recovery plan; and the Company’s belief that in the ordinary course of business, its source or use of cash from operating activities may vary on a quarterly basis as a result of a number of factors, including the timing of working capital flows;
|
(xi)
|
the Company’s expectations regarding its future net periodic benefit cost for its U.S. and international defined benefit plans;
|
(xii)
|
the Company's expectation that its tax provision and effective tax rate in any individual quarter and year-to-date period will vary and may not be indicative of the Company's tax provision and effective tax rate for the full year and, with respect to the Tax Act, the Company’s expectation that it will not have a transition tax liability due to its deficit in foreign earnings as of the applicable measurement dates, that the Tax Act’s limitation on interest deductibility will not impact the Company’s 2019 federal cash taxes due to its net operating loss carryover position, and that the Tax Act will not have a material impact on its cash taxes or liquidity in 2019, as well as the Company's expectations regarding whether it will be required to establish additional valuation allowances on its deferred tax assets;
|
(xiii)
|
the Company's belief that the allegations contained in the Third Consolidated Amended Class Action Complaint are without merit and its plans to continue to vigorously defend against them and its belief that the outcome of all pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows, but that in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company’s operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company’s income for that particular period;
|
(xiv)
|
certain estimates used by management in estimating the fair value of the assets acquired in the Elizabeth Arden Acquisition and in valuing other assets and liabilities;
|
(xv)
|
the Company's expected benefits and other impacts from the Elizabeth Arden Acquisition; and
|
(xvi)
|
the Company’s expectations regarding its implementation of the remediation plan to address the material weakness that it identified in its internal control over financial reporting, as described in Item 9A. “Controls and Procedures” of this 2018 Form 10-K.
|
(i)
|
unanticipated circumstances or results affecting the Company's financial performance and or sales growth, including: greater than anticipated levels of consumers choosing to purchase their beauty products through e-commerce and other social media channels and/or greater than anticipated declines in the brick-and-mortar retail channel, or either of those conditions occurring at a rate faster than anticipated; the Company’s inability to address the pace and impact of the new commercial landscape, such as its inability to enhance its e-commerce and social media capabilities and/or increase its penetration of e-commerce and social media channels; the Company’s inability to drive a successful long-term omni-channel strategy and significantly increase its e-commerce penetration; difficulties, delays and/or the Company's inability to (in whole or in part) develop and implement effective content to enhance its online retail position, improve its consumer engagement across social media platforms and/or transform its technology and data to support efficient management of its digital infrastructure; the Company incurring greater than anticipated levels of expenses and/or debt to facilitate the foregoing objectives, which could result in, among other things, less than anticipated revenues and/or profitability; decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors; decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; and/or supply disruptions at the Company’s manufacturing facilities; changes in consumer preferences, such as reduced consumer demand for the Company's color cosmetics and other current products, including new product launches; changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to the continuing consumption declines in core beauty categories in the mass retail channel in North America; lower than expected customer acceptance or consumer acceptance of, or less than anticipated results from, the Company’s existing or new products; higher than expected retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; higher than expected restructuring or severance costs, acquisition costs and/or acquisition-related integration costs and capital expenditures, including, without limitation, costs and expenses related to the EA Integration Restructuring Program and/or the 2018 Optimization Program; higher than expected pension expense and/or cash contributions under its benefit plans, costs related to litigation, advertising, promotional and/or marketing expenses or lower than expected results from the Company’s advertising, promotional, pricing and/or marketing plans; higher than expected sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise or decreased sales of the Company’s existing or new products; actions by the Company’s customers, such as greater than expected inventory management and/or de-stocking, and greater than anticipated space reconfigurations or reductions in display space and/or product discontinuances or a greater than expected impact from pricing, marketing, advertising and/or promotional strategies by the Company's customers; and changes in the competitive environment and actions by the Company's competitors, including, among other things, business combinations, technological breakthroughs, implementation of new pricing strategies, new product offerings, increased advertising, promotional and marketing spending and advertising, promotional and/or marketing successes by competitors;
|
(ii)
|
in addition to the items discussed in (i) above, the effects of and changes in economic conditions (such as volatility in the financial markets, inflation, increasing interest rates, monetary conditions and foreign currency fluctuations, tariffs, foreign currency controls and/or government-mandated pricing controls, as well as in trade, monetary, fiscal and tax policies in international markets) and political conditions (such as military actions and terrorist activities);
|
(iii)
|
unanticipated costs or difficulties or delays in completing projects associated with continuing to execute the Company’s business initiatives or lower than expected revenues or the inability to create value through improving our financial performance as a result of such initiatives, including lower than expected sales, or higher than expected costs, including as may arise from any additional repositioning, repackaging or reformulating of one or more brands or product lines, launching of new product lines, including higher than expected expenses, including for sales returns, for launching its new products, acquiring businesses or brands (including through licensing transactions, if any), divesting or discontinuing non-core business lines (which may include exiting certain territories or converting the Company's go-to-trade structure in certain countries to other business models), further refining its approach to retail merchandising and/or difficulties, delays or increased costs in connection with taking further actions to optimize the Company’s manufacturing, sourcing, supply chain or organizational size and structure (including difficulties or delays in and/or the Company’s inability to optimally integrate the Elizabeth Arden business, more than expected costs to fully implement such integration or delays in fully implementing the integration and/or less than expected benefits from the EA Integration Restructuring Program and/or the 2018 Optimization Program, more than expected costs in implementing such programs and/or difficulties or delays, in whole or in part, in executing the EA Integration Restructuring Program and/or the 2018 Optimization Program, which could cause the Company not to realize the projected cost reductions), as well as the unavailability of cash generated by operations, cash on hand and/or funds under the 2016 Revolving Credit Facility or from other permitted additional sources of capital to fund such potential activities, as well as the unavailability of funds due to potential mandatory repayment obligations under the 2018 Asset-Based Term Facility;
|
(iv)
|
difficulties, delays in and/or less than expected results from the Company’s efforts to resolve the customer service level disruptions resulting from the launch of its new ERP system; the ERP implementation continuing to disrupt the Company's operations and its ability to fulfill customer orders; the Company incurring greater than expected expedited shipping fees and other unanticipated expenses in connection with the remedial actions; and/or greater than expected adverse customer reaction to the service level disruptions that could lead to decreased shelf space or loss of sales;
|
(v)
|
difficulties, delays or unanticipated costs or charges or less than expected cost reductions and other benefits resulting from the Company's restructuring activities, such as (A) in connection with the EA Integration Restructuring Program: (1) difficulties, delays or the inability of the Company to successfully complete the EA Integration Restructuring Program, in whole or in part, which could result in less than expected operating and financial benefits from such actions; (2) difficulties, delays or the inability of the Company to realize, in whole or in part, the anticipated benefits from the EA Integration Restructuring Program, such as difficulties with, delays in or the Company’s inability to generate certain reductions in its SG&A and/or eliminate certain positions; (3) delays in completing the EA Integration Restructuring Program, which could reduce the benefits realized from such activities; (4) higher than anticipated restructuring charges and/or payments in connection with completing the EA Integration Restructuring Program and/or changes in the expected timing of such charges and/or payments; (5) greater than anticipated costs or charges or less than anticipated cost reductions or other benefits from the EA Integration Restructuring Program; and/or (6) the risk that such program may not satisfy the Company’s objectives; and (B) in connection with the 2018 Optimization Program: (1) difficulties with, delays in or the Company’s inability to successfully complete the actions underlying the 2018 Optimization Program, in whole or in part, which could result in less than expected operating and financial benefits from such actions, such as difficulties with, delays in or the Company’s inability to generate reductions in its cost base and/or overhead costs; (2) higher than anticipated restructuring charges and/or payments and/or changes in the expected timing of such charges and/or payments; (3) delays in completing the actions underlying the 2018 Optimization Program, which could reduce and/or defer the benefits expected to be realized from such activities; and/or (4) less than anticipated annualized cost reductions from the 2018 Optimization Program and/or changes in the timing of realizing such cost reductions, such as due to less than anticipated resources to fund such activities and/or more than expected costs to achieve the expected cost reductions;
|
(vi)
|
lower than expected operating revenues, cash on hand and/or funds available under the 2016 Revolving Credit Facility and/or other permitted lines of credit or generated from cost reductions related to the 2018 Optimization Program and/or other cost control initiatives; higher than anticipated operating expenses, such as referred to in clause (viii) below; and/or less than anticipated cash generated by the Company's operations or unanticipated restrictions or taxes on repatriation of foreign earnings;
|
(vii)
|
the unavailability of funds under Products Corporation's 2016 Revolving Credit Facility or other permitted lines of credit; the unavailability of funds under the 2018 Asset-Based Term Facility, such as due to reductions in the applicable borrowing base that could require certain mandatory prepayments; the unavailability of funds from difficulties, delays in or the Company's inability to take other measures, such as reducing discretionary spending and/or less than expected liquidity from cost reductions resulting from the implementation of the 2018 Optimization Program and from other cost reduction initiatives, such as due to the Company’s inability to implement, in whole or in part, cost reduction initiatives under the 2018 Optimization Program;
|
(viii)
|
higher than expected operating expenses, sales returns, working capital expenses, integration and/or synergy costs related to the Elizabeth Arden Acquisition, permanent wall display costs, capital expenditures, debt service payments, cash tax payments, cash pension plan contributions, other post-retirement benefit plan contributions and/or net periodic benefit costs for the pension and other post-retirement benefit plans, restructuring costs (including, without limitation, in connection with implementing the EA Integration Restructuring Program and/or the 2018 Optimization Program), severance and discontinued operations not otherwise included in the Company’s restructuring programs, debt and/or equity repurchases, costs related to litigation and/or payments in connection with business and/or brand acquisitions (including, without limitation, through licensing transactions, if any), and discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade;
|
(ix)
|
unexpected significant impacts on the Company from changes in interest rates or foreign exchange rates;
|
(x)
|
difficulties, delays or the inability of the Company to efficiently manage its cash and working capital;
|
(xi)
|
lower than expected returns on pension plan assets and/or lower discount rates, which could result in higher than expected cash contributions, higher net periodic benefit costs and/or less than expected net periodic benefit income;
|
(xii)
|
unexpected significant variances in the Company's tax provision, effective tax rate and/or unrecognized tax benefits, whether due to the enactment of the Tax Act or otherwise, such as due to the issuance of unfavorable guidance, interpretations, technical clarifications and/or technical corrections legislation by the U.S. Congress, the U.S. Treasury Department or the IRS, unexpected changes in foreign, state or local tax regimes in response to the Tax Act, and/or changes in estimates that may impact the calculation of the Company's tax provisions, as well as changes in circumstances that could adversely impact the Company's expectations regarding the establishment of additional valuation allowances on its deferred tax assets;
|
(xiii)
|
unanticipated adverse effects on the Company’s business, prospects, results of operations, financial condition and/or cash flows as a result of unexpected developments with respect to the Company's legal proceedings;
|
(xiv)
|
changes in the fair values of the assets acquired in the Elizabeth Arden Acquisition due to, among other things, unanticipated future performance of the acquired licenses and/or other brands;
|
(xv)
|
difficulties with, delays in and/or the Company’s inability to achieve, in whole or in part, or within the expected timeframe the expected benefits from the Elizabeth Arden Acquisition, such as the Company being unable to successfully implement, in whole or in part, its integration strategies; and/or
|
(xvi)
|
difficulties or delays that could affect the Company’s ability to effectively implement the remediation plan, in whole or in part, to address the material weakness that it identified in its internal control over financial reporting, as described in Item 9A. “Controls and Procedures” of this 2018 Form 10-K.
|
(a)
|
List of documents filed as part of this Report:
|
|
(1) Consolidated Financial Statements and Reports of Independent Registered Public Accounting Firm included herein: See Index on page F-1.
|
|
(2) Financial Statement Schedule: See Index on page F-1.
|
|
All other schedules are omitted as they are inapplicable or the required information is furnished in the Company’s Consolidated Financial Statements or the Notes thereto.
|
|
(3) List of Exhibits:
|
2.
|
Plan of acquisition, reorganization, arrangement, liquidation or succession.
|
2.1
|
|
2.2
|
|
3.
|
Certificate of Incorporation and By-laws.
|
3.1
|
|
3.2
|
|
4.
|
Instruments Defining the Rights of Security Holders, Including Indentures.
|
4.1
|
|
4.2
|
|
4.3
|
|
4.4
|
|
4.5
|
|
4.6
|
|
4.7
|
4.8
|
|
4.9
|
|
4.10
|
|
4.11
|
|
4.12
|
|
4.13
|
|
4.14
|
|
4.15
|
|
4.16
|
|
4.17
|
|
4.18
|
|
4.19
|
|
4.20
|
|
4.21
|
|
4.22
|
|
4.23
|
4.24
|
|
4.25
|
|
4.26
|
|
4.27
|
|
4.28
|
|
|
|
10.
|
Material Contracts.
|
10.1
|
|
10.2
|
|
10.3
|
|
10.4
|
|
10.5
|
|
10.6
|
|
10.7
|
|
10.8
|
|
10.9
|
|
10.10
|
|
10.11
|
|
10.12
|
Amended and Restated Revlon Pension Equalization Plan, amended and restated as of December 14, 1998 (the "PEP") (incorporated by reference to Exhibit 10.15 to Revlon’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998 filed with the SEC on March 3, 1999).
|
10.13
|
|
10.14
|
10.15
|
Benefit Plans Assumption Agreement, dated as of July 1, 1992, by and among Revlon Holdings, Revlon and Products Corporation (incorporated by reference to Exhibit 10.25 to Products Corporation’s Annual Report on Form 10-K for the fiscal year ended December 31, 1992 filed with the SEC on March 12, 1993).
|
10.16
|
|
10.17
|
|
*10.18
|
|
10.19
|
|
21.
|
Subsidiaries.
|
*21.1
|
|
23.
|
Consents of Experts and Counsel.
|
*23.1
|
|
24.
|
Powers of Attorney.
|
*24.1
|
|
*24.2
|
|
*24.3
|
|
*24.4
|
|
*24.5
|
|
*24.6
|
|
*24.7
|
|
*24.8
|
|
*24.9
|
|
*24.10
|
|
*24.11
|
|
*31.1
|
|
*31.2
|
|
**32.1
|
|
**32.2
|
|
*99.1
|
|
|
|
*101.INS
|
XBRL Instance Document
|
*101.SCH
|
XBRL Taxonomy Extension Schema
|
*101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
*101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
*101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
*101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
Page
|
|
||
|
||
Audited Financial Statements:
|
|
|
|
||
|
||
|
||
|
||
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
|
|
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
87.3
|
|
|
$
|
87.1
|
|
Trade receivables, less allowance for doubtful accounts of $15.6 and $13.5 as of December 31, 2018 and December 31, 2017, respectively
|
431.3
|
|
|
444.8
|
|
||
Inventories
|
523.2
|
|
|
497.9
|
|
||
Prepaid expenses and other assets
|
152.0
|
|
|
113.4
|
|
||
Total current assets
|
1,193.8
|
|
|
1,143.2
|
|
||
Property, plant and equipment, net of accumulated depreciation of $425.2 and $385.5 as of December 31, 2018 and December 31, 2017, respectively
|
354.5
|
|
|
372.7
|
|
||
Deferred income taxes
|
131.8
|
|
|
138.0
|
|
||
Goodwill
|
673.9
|
|
|
692.5
|
|
||
Intangible assets, net of accumulated amortization of $187.3 and $130.9 as of December 31, 2018 and December 31, 2017, respectively
|
532.0
|
|
|
592.1
|
|
||
Other assets
|
130.8
|
|
|
118.4
|
|
||
Total assets
|
$
|
3,016.8
|
|
|
$
|
3,056.9
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Short-term borrowings
|
$
|
9.3
|
|
|
$
|
12.4
|
|
Current portion of long-term debt
|
348.1
|
|
|
170.2
|
|
||
Accounts payable
|
332.1
|
|
|
336.9
|
|
||
Accrued expenses and other current liabilities
|
430.9
|
|
|
412.8
|
|
||
Total current liabilities
|
1,120.4
|
|
|
932.3
|
|
||
Long-term debt
|
2,727.7
|
|
|
2,653.7
|
|
||
Long-term pension and other post-retirement plan liabilities
|
169.0
|
|
|
172.8
|
|
||
Other long-term liabilities
|
56.5
|
|
|
68.5
|
|
||
Stockholders’ deficiency:
|
|
|
|
||||
Class A Common Stock, par value $0.01 per share: 900,000,000 shares authorized; 55,556,466 and 54,556,100 shares issued as of December 31, 2018 and December 31, 2017, respectively
|
0.5
|
|
|
0.5
|
|
||
Additional paid-in capital
|
1,063.8
|
|
|
1,040.0
|
|
||
Treasury stock, at cost: 1,533,320 and 1,114,528 shares of Class A Common Stock as of December 31, 2018 and December 31, 2017, respectively
|
(31.9
|
)
|
|
(21.7
|
)
|
||
Accumulated deficit
|
(1,855.0
|
)
|
|
(1,560.8
|
)
|
||
Accumulated other comprehensive loss
|
(234.2
|
)
|
|
(228.4
|
)
|
||
Total stockholders’ deficiency
|
(1,056.8
|
)
|
|
(770.4
|
)
|
||
Total liabilities and stockholders’ deficiency
|
$
|
3,016.8
|
|
|
$
|
3,056.9
|
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
|
|
|
(as adjusted)
(*)
|
||||
Net sales
|
$
|
2,564.5
|
|
|
$
|
2,693.7
|
|
Cost of sales
|
1,117.0
|
|
|
1,152.3
|
|
||
Gross profit
|
1,447.5
|
|
|
1,541.4
|
|
||
Selling, general and administrative expenses
|
1,460.5
|
|
|
1,468.1
|
|
||
Acquisition and integration costs
|
13.9
|
|
|
52.9
|
|
||
Restructuring charges and other, net
|
20.2
|
|
|
33.4
|
|
||
Impairment charges
|
18.0
|
|
|
10.8
|
|
||
Loss on disposal of minority investment
|
20.1
|
|
|
—
|
|
||
Operating loss
|
(85.2
|
)
|
|
(23.8
|
)
|
||
Other expenses:
|
|
|
|
||||
Interest expense
|
176.6
|
|
|
149.8
|
|
||
Amortization of debt issuance costs
|
13.0
|
|
|
9.1
|
|
||
Foreign currency losses (gains), net
|
15.8
|
|
|
(18.5
|
)
|
||
Miscellaneous, net
|
1.3
|
|
|
(0.7
|
)
|
||
Other expenses
|
$
|
206.7
|
|
|
139.7
|
|
|
Loss from continuing operations before income taxes
|
(291.9
|
)
|
|
(163.5
|
)
|
||
Provision for income taxes
|
2.2
|
|
|
21.8
|
|
||
Loss from continuing operations, net of taxes
|
(294.1
|
)
|
|
(185.3
|
)
|
||
(Loss) income from discontinued operations, net of taxes
|
(0.1
|
)
|
|
2.1
|
|
||
Net loss
|
$
|
(294.2
|
)
|
|
$
|
(183.2
|
)
|
Other comprehensive (loss) income:
|
|
|
|
||||
Foreign currency translation adjustments, net of tax
(a)
|
(9.4
|
)
|
|
9.0
|
|
||
Amortization of pension related costs, net of tax
(b)(c)
|
8.4
|
|
|
8.1
|
|
||
Pension re-measurement, net of tax
(d)
|
(5.5
|
)
|
|
1.8
|
|
||
Pension curtailment, net of tax
(e)
|
—
|
|
|
2.1
|
|
||
Reclassification into earnings of accumulated losses from the de-designated 2013 Interest Rate Swap, net of tax
(f)
|
0.7
|
|
|
2.3
|
|
||
Other comprehensive (loss) income, net
|
(5.8
|
)
|
|
23.3
|
|
||
Total comprehensive loss
|
$
|
(300.0
|
)
|
|
$
|
(159.9
|
)
|
|
|
|
|
||||
Basic (loss) earnings per common share:
|
|
|
|
||||
Continuing operations
|
$
|
(5.57
|
)
|
|
$
|
(3.52
|
)
|
Discontinued operations
|
—
|
|
|
0.04
|
|
||
Net loss
|
$
|
(5.57
|
)
|
|
$
|
(3.48
|
)
|
|
|
|
|
||||
Diluted (loss) earnings per common share:
|
|
|
|
||||
Continuing operations
|
$
|
(5.57
|
)
|
|
$
|
(3.52
|
)
|
Discontinued operations
|
—
|
|
|
0.04
|
|
||
Net loss
|
$
|
(5.57
|
)
|
|
$
|
(3.48
|
)
|
|
|
|
|
||||
Weighted average number of common shares outstanding:
|
|
|
|
||||
Basic
|
52,797,686
|
|
|
52,597,582
|
|
||
Diluted
|
52,797,686
|
|
|
52,597,582
|
|
(*)
|
Adjusted as a result of the adoption of certain accounting pronouncements during 2018. See Note
1
, "Description of Business and Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements," for details of these adjustments.
|
(a)
|
Net of tax benefit of
$0.1 million
and $
0.4 million
for the
years ended December 31,
2018
and
2017
, respectively.
|
(b)
|
Net of tax expense of
$1.0 million
and $
1.6 million
for the
years ended December 31,
2018
and
2017
, respectively.
|
(c)
|
This amount is included in the computation of net periodic benefit costs (income). See Note
13
, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).
|
(d)
|
Net of tax benefit of
$2.5 million
and
$0.3 million
for the
years ended December 31,
2018
and
2017
, respectively.
|
(e)
|
Net of tax expense of
$0.3 million
for the
year ended December 31,
2017
.
|
(f)
|
Net of tax benefit of
$0.5 million
and
$1.4 million
for the
years ended December 31,
2018
and
2017
, respectively.
|
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Treasury Stock
|
|
Accumulated Deficit
|
|
Accumulated Other Comprehensive Loss
|
|
Total Stockholders’ Deficiency
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Balance, January 1, 2017
|
$
|
0.5
|
|
|
$
|
1,033.2
|
|
|
$
|
(19.2
|
)
|
|
$
|
(1,377.6
|
)
|
|
$
|
(251.7
|
)
|
|
(614.8
|
)
|
|
Treasury stock acquired, at cost
(a)
|
—
|
|
|
—
|
|
|
(2.5
|
)
|
|
—
|
|
|
—
|
|
|
(2.5
|
)
|
||||||
Stock-based compensation amortization
|
—
|
|
|
6.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6.8
|
|
||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(183.2
|
)
|
|
—
|
|
|
(183.2
|
)
|
||||||
Other comprehensive income, net
(b)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
23.3
|
|
|
23.3
|
|
||||||
Balance, December 31, 2017
|
$
|
0.5
|
|
|
$
|
1,040.0
|
|
|
$
|
(21.7
|
)
|
|
$
|
(1,560.8
|
)
|
|
$
|
(228.4
|
)
|
|
$
|
(770.4
|
)
|
Treasury stock acquired, at cost
(a)
|
—
|
|
|
6.6
|
|
|
(10.2
|
)
|
|
—
|
|
|
—
|
|
|
(3.6
|
)
|
||||||
Stock-based compensation amortization
|
—
|
|
|
17.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
17.2
|
|
||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(294.2
|
)
|
|
—
|
|
|
(294.2
|
)
|
||||||
Other comprehensive loss, net
(b)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5.8
|
)
|
|
(5.8
|
)
|
||||||
Balance, December 31, 2018
|
$
|
0.5
|
|
|
$
|
1,063.8
|
|
|
$
|
(31.9
|
)
|
|
$
|
(1,855.0
|
)
|
|
$
|
(234.2
|
)
|
|
(1,056.8
|
)
|
(a)
|
Pursuant to the share withholding provisions of the Fourth Amended and Restated Revlon, Inc. Stock Plan (the "Stock Plan"), the Company withheld an aggregate of
167,297
and
89,620
shares of Revlon Class A Common Stock during
2018
and
2017
to satisfy certain minimum statutory tax withholding requirements related to the vesting of restricted shares for certain senior executives. These withheld shares were recorded as treasury stock using the cost method, at a weighted-average price per share of
$21.42
and
$27.67
during
2018
and
2017
, based on the closing price of Revlon Class A Common Stock as reported on the New York Stock Exchange (the "NYSE") consolidated tape on each respective vesting date, for a total of
$3.6 million
and
$2.5 million
, in
2018
and
2017
, respectively. In addition, during
2018
, the Company transferred to treasury stock
251,495
unvested restricted shares forfeited upon the departure of certain executives. These shares were recorded as treasury stock using the cost method, at a weighted average price of
$26.26
per share, based on the grant date fair values of the forfeited shares, for a total of
$6.6 million
. See Note
14
, "Stock Compensation Plan," for details regarding restricted stock awards under the Stock Plan.
|
(b)
|
See Note
16
, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during
2018
and
2017
.
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
||||
Net loss
|
$
|
(294.2
|
)
|
|
$
|
(183.2
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
||||
Depreciation and amortization
|
177.2
|
|
|
155.8
|
|
||
Foreign currency losses (gains) from re-measurement
|
15.8
|
|
|
(22.5
|
)
|
||
Amortization of debt discount
|
1.4
|
|
|
1.2
|
|
||
Stock-based compensation amortization
|
17.2
|
|
|
6.8
|
|
||
Impairment charges
|
18.0
|
|
|
10.8
|
|
||
Provision for deferred income taxes
|
1.7
|
|
|
22.6
|
|
||
Amortization of debt issuance costs
|
13.0
|
|
|
9.1
|
|
||
Non-cash loss on disposal of minority investment
|
18.6
|
|
|
—
|
|
||
Loss on sale of certain assets
|
0.8
|
|
|
1.6
|
|
||
Pension and other post-retirement cost
|
2.6
|
|
|
1.5
|
|
||
Change in assets and liabilities:
|
|
|
|
||||
Increase in trade receivables
|
(0.3
|
)
|
|
(9.9
|
)
|
||
Increase in inventories
|
(36.4
|
)
|
|
(63.0
|
)
|
||
Increase in prepaid expenses and other current assets
|
(42.8
|
)
|
|
(21.2
|
)
|
||
Increase in accounts payable
|
1.6
|
|
|
26.8
|
|
||
Increase in accrued expenses and other current liabilities
|
23.9
|
|
|
12.3
|
|
||
Pension and other post-retirement plan contributions
|
(8.8
|
)
|
|
(8.5
|
)
|
||
Purchases of permanent displays
|
(80.7
|
)
|
|
(65.5
|
)
|
||
Other, net
|
0.6
|
|
|
(14.0
|
)
|
||
Net cash used in operating activities
|
(170.8
|
)
|
|
(139.3
|
)
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
||||
Capital expenditures
|
(57.2
|
)
|
|
(108.3
|
)
|
||
Net cash used in investing activities
|
(57.2
|
)
|
|
(108.3
|
)
|
||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
||||
Net (decrease) increase in short-term borrowings and overdraft
|
(1.1
|
)
|
|
3.3
|
|
||
Net borrowings under the 2016 Revolving Credit Facility
|
178.0
|
|
|
157.0
|
|
||
Net borrowings under the 2018 Foreign Asset-Based Term Loan
|
88.9
|
|
|
—
|
|
||
Repayments under the 2016 Term Loan Facility
|
(18.0
|
)
|
|
(18.0
|
)
|
||
Payment of financing costs
|
(9.7
|
)
|
|
(1.2
|
)
|
||
Tax withholdings related to net share settlements of restricted stock units and awards
|
(3.6
|
)
|
|
(2.5
|
)
|
||
Other financing activities
|
(1.4
|
)
|
|
(1.7
|
)
|
||
Net cash provided by financing activities
|
233.1
|
|
|
136.9
|
|
||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(5.0
|
)
|
|
11.3
|
|
||
Net increase (decrease) in cash, cash equivalents and restricted cash
|
0.1
|
|
|
(99.4
|
)
|
||
Cash, cash equivalents and restricted cash at beginning of period
(a)
|
87.4
|
|
|
186.8
|
|
||
Cash, cash equivalents and restricted cash at end of period
(a)
|
$
|
87.5
|
|
|
$
|
87.4
|
|
Supplemental schedule of cash flow information:
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
||||
Interest
|
$
|
163.7
|
|
|
$
|
149.1
|
|
Income taxes, net of refunds
|
16.0
|
|
|
0.4
|
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Cash and cash equivalents
|
|
$
|
87.3
|
|
|
$
|
87.1
|
|
Restricted cash
(a)
|
|
0.2
|
|
|
0.3
|
|
||
Total cash, cash equivalents and restricted cash
|
|
$
|
87.5
|
|
|
$
|
87.4
|
|
|
Restructuring Charges and Other, Net
|
|
|
|
|
||||||||||||||
|
Employee Severance and Other Personnel Benefits
|
|
Other Costs
|
|
Total Restructuring Charges
|
|
Other Related Charges
(a)
|
|
Total Restructuring and Related Charges
|
||||||||||
Cumulative charges incurred through December 31, 2018
|
$
|
4.5
|
|
|
$
|
—
|
|
|
$
|
4.5
|
|
|
$
|
1.2
|
|
|
$
|
5.7
|
|
|
|
Charges incurred during the year ended December 31, 2018
|
||
Revlon
|
|
$
|
1.9
|
|
Elizabeth Arden
|
|
0.9
|
|
|
Portfolio
|
|
1.0
|
|
|
Fragrances
|
|
0.7
|
|
|
Total
|
|
$
|
4.5
|
|
|
Restructuring Charges and Other, Net
|
|
|
|
|
|
|
||||||||||||||||
|
Employee Severance and Other Personnel Benefits
|
|
Lease Termination and Other Costs
|
|
Total Restructuring Charges
|
|
Inventory Adjustments
(b)
|
|
Other Related Charges
(c)
|
|
Total Restructuring and Related Charges
|
||||||||||||
Charges incurred through December 31, 2017
|
$
|
62.8
|
|
|
$
|
5.0
|
|
|
$
|
67.8
|
|
|
$
|
1.4
|
|
|
$
|
3.0
|
|
|
$
|
72.2
|
|
Charges incurred during the year ended December 31, 2018
|
9.4
|
|
|
0.1
|
|
(a)
|
9.5
|
|
|
0.5
|
|
|
—
|
|
|
10.0
|
|
||||||
Cumulative charges incurred through December 31, 2018
|
$
|
72.2
|
|
|
$
|
5.1
|
|
|
$
|
77.3
|
|
|
$
|
1.9
|
|
|
$
|
3.0
|
|
|
$
|
82.2
|
|
|
|
Charges incurred during the year ended December 31, 2018
|
|
Cumulative charges incurred through December 31, 2018
|
||||
Revlon
|
|
$
|
8.3
|
|
|
$
|
32.9
|
|
Elizabeth Arden
|
|
0.5
|
|
|
13.3
|
|
||
Portfolio
|
|
(0.3
|
)
|
|
13.1
|
|
||
Fragrances
|
|
1.0
|
|
|
18.0
|
|
||
Total
|
|
$
|
9.5
|
|
|
$
|
77.3
|
|
|
|
|
|
|
|
|
Utilized, Net
|
|
|
||||||||||||||
Liability
Balance at January 1, 2018
|
|
Expense (Income), Net
|
|
Foreign Currency Translation
|
|
Cash
|
|
Non-cash
|
|
Liability Balance at December 31, 2018
|
|||||||||||||
2018 Optimization Program:
(a)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Employee severance and other personnel benefits
|
$
|
—
|
|
|
$
|
4.5
|
|
|
$
|
—
|
|
|
$
|
(0.8
|
)
|
|
$
|
—
|
|
|
$
|
3.7
|
|
Other
|
—
|
|
|
1.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.2
|
|
||||||
Total 2018 Optimization Program
|
—
|
|
|
5.7
|
|
|
—
|
|
|
(0.8
|
)
|
|
—
|
|
|
4.9
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
EA Integration Restructuring Program:
(b)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Employee severance and other personnel benefits
|
25.8
|
|
|
9.4
|
|
|
(0.3
|
)
|
|
(21.1
|
)
|
|
—
|
|
|
13.8
|
|
||||||
Other
|
3.9
|
|
|
0.6
|
|
|
—
|
|
|
(0.3
|
)
|
|
—
|
|
|
4.2
|
|
||||||
Total EA Integration Restructuring Program
|
29.7
|
|
|
10.0
|
|
|
(0.3
|
)
|
|
(21.4
|
)
|
|
—
|
|
|
18.0
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other individually immaterial actions:
(c)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Employee severance and other personnel benefits
|
2.5
|
|
|
5.1
|
|
|
—
|
|
|
(3.0
|
)
|
|
—
|
|
|
4.6
|
|
||||||
Other
|
1.7
|
|
|
1.0
|
|
|
(0.1
|
)
|
|
(1.8
|
)
|
|
—
|
|
|
0.8
|
|
||||||
Total other individually immaterial actions
|
4.2
|
|
|
6.1
|
|
|
(0.1
|
)
|
|
(4.8
|
)
|
|
—
|
|
|
5.4
|
|
||||||
Total restructuring reserve
|
$
|
33.9
|
|
|
$
|
21.8
|
|
|
$
|
(0.4
|
)
|
|
$
|
(27.0
|
)
|
|
$
|
—
|
|
|
$
|
28.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
Utilized, Net
|
|
|
||||||||||||||
Liability
Balance at January 1, 2017
|
|
Expense (Income), Net
|
|
Foreign Currency Translation
|
|
Cash
|
|
Non-cash
|
|
Liability Balance at December 31, 2017
|
|||||||||||||
EA Integration Restructuring Program:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Employee severance and other personnel benefits
|
$
|
31.5
|
|
|
$
|
31.3
|
|
|
$
|
—
|
|
|
$
|
(37.0
|
)
|
|
$
|
—
|
|
|
$
|
25.8
|
|
Other
|
3.0
|
|
|
6.4
|
|
|
—
|
|
|
(5.5
|
)
|
|
—
|
|
|
3.9
|
|
||||||
Total EA Integration Restructuring Program
|
34.5
|
|
|
37.7
|
|
|
—
|
|
|
(42.5
|
)
|
|
—
|
|
|
29.7
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other individually immaterial actions:
(d)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Employee severance and other personnel benefits
|
7.1
|
|
|
(2.6
|
)
|
|
—
|
|
|
(2.0
|
)
|
|
—
|
|
|
2.5
|
|
||||||
Other
|
1.2
|
|
|
1.1
|
|
|
0.1
|
|
|
(0.7
|
)
|
|
—
|
|
|
1.7
|
|
||||||
Total other individually immaterial actions
|
8.3
|
|
|
(1.5
|
)
|
|
0.1
|
|
|
(2.7
|
)
|
|
—
|
|
|
4.2
|
|
||||||
Total restructuring reserve
|
$
|
42.8
|
|
|
$
|
36.2
|
|
|
$
|
0.1
|
|
|
$
|
(45.2
|
)
|
|
$
|
—
|
|
|
$
|
33.9
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Net sales
|
|
$
|
—
|
|
|
$
|
—
|
|
(Loss) income from discontinued operations, before taxes
|
|
(0.1
|
)
|
|
2.4
|
|
||
Provision for income taxes
|
|
—
|
|
|
0.3
|
|
||
(Loss) income from discontinued operations, net of taxes
|
|
(0.1
|
)
|
|
2.1
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Cash and cash equivalents
|
$
|
1.1
|
|
|
$
|
1.3
|
|
Trade receivables, net
|
0.2
|
|
|
0.2
|
|
||
Total current assets
|
1.3
|
|
|
1.5
|
|
||
Total assets
|
$
|
1.3
|
|
|
$
|
1.5
|
|
|
|
|
|
||||
Accounts payable
|
$
|
0.5
|
|
|
$
|
0.5
|
|
Accrued expenses and other
|
3.3
|
|
|
3.5
|
|
||
Total current liabilities
|
3.8
|
|
|
4.0
|
|
||
Total liabilities
|
$
|
3.8
|
|
|
$
|
4.0
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Raw materials and supplies
|
$
|
143.5
|
|
|
$
|
123.4
|
|
Work-in-process
|
5.6
|
|
|
22.0
|
|
||
Finished goods
|
374.1
|
|
|
352.5
|
|
||
|
$
|
523.2
|
|
|
$
|
497.9
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Prepaid expenses
|
$
|
71.5
|
|
|
$
|
43.3
|
|
Other
|
80.5
|
|
|
70.1
|
|
||
|
$
|
152.0
|
|
|
$
|
113.4
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Land and improvements
|
$
|
11.2
|
|
|
$
|
11.6
|
|
Building and improvements
|
103.2
|
|
|
97.0
|
|
||
Machinery, equipment and capital leases
|
286.7
|
|
|
275.1
|
|
||
Office furniture, fixtures and capitalized software
|
220.0
|
|
|
168.3
|
|
||
Counters and trade fixtures
|
56.0
|
|
|
62.0
|
|
||
Leasehold improvements
|
51.5
|
|
|
51.4
|
|
||
Construction-in-progress
|
51.1
|
|
|
92.8
|
|
||
Property, plant and equipment, gross
|
779.7
|
|
|
758.2
|
|
||
Accumulated depreciation and amortization
|
(425.2
|
)
|
|
(385.5
|
)
|
||
Property, plant and equipment, net
|
$
|
354.5
|
|
|
$
|
372.7
|
|
|
Revlon
|
|
Portfolio
|
|
Elizabeth Arden
|
|
Fragrances
|
|
Total
|
||||||||||
Balance at January 1, 2017
(a)
|
$
|
265.3
|
|
|
$
|
198.8
|
|
|
$
|
104.6
|
|
|
$
|
120.8
|
|
|
$
|
689.5
|
|
Measurement Period Adjustments
(b)
|
—
|
|
|
|
|
|
12.3
|
|
|
|
|
|
12.3
|
|
|||||
Foreign currency translation adjustment
|
—
|
|
|
1.5
|
|
|
|
|
|
|
|
|
1.5
|
|
|||||
Goodwill impairment charge
(a)
|
|
|
|
(10.8
|
)
|
|
|
|
|
|
|
|
(10.8
|
)
|
|||||
Balance at December 31, 2017
(a)
|
$
|
265.3
|
|
|
$
|
189.5
|
|
|
$
|
116.9
|
|
|
$
|
120.8
|
|
|
$
|
692.5
|
|
Foreign currency translation adjustment
|
(0.3
|
)
|
|
(0.3
|
)
|
|
—
|
|
|
—
|
|
|
(0.6
|
)
|
|||||
Goodwill impairment charge
|
—
|
|
|
(18.0
|
)
|
|
—
|
|
|
—
|
|
|
(18.0
|
)
|
|||||
Balance at December 31, 2018
|
$
|
265.0
|
|
|
$
|
171.2
|
|
|
$
|
116.9
|
|
|
$
|
120.8
|
|
|
$
|
673.9
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cumulative goodwill impairment charges
(c)
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(55.2
|
)
|
|
December 31, 2018
|
||||||||||||
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
Weighted-Average Useful Life (in Years)
|
||||||
Finite-lived intangible assets:
|
|
|
|
|
|
|
|
||||||
Trademarks and licenses
|
$
|
272.3
|
|
|
$
|
(94.3
|
)
|
|
$
|
178.0
|
|
|
13
|
Customer relationships
|
248.6
|
|
|
(77.9
|
)
|
|
170.7
|
|
|
12
|
|||
Patents and internally-developed intellectual property
|
20.9
|
|
|
(10.1
|
)
|
|
10.8
|
|
|
6
|
|||
Distribution rights
|
31.0
|
|
|
(4.0
|
)
|
|
27.0
|
|
|
16
|
|||
Other
|
1.3
|
|
|
(1.0
|
)
|
|
0.3
|
|
|
1
|
|||
Total finite-lived intangible assets
|
$
|
574.1
|
|
|
$
|
(187.3
|
)
|
|
$
|
386.8
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
||||||
Trade names
|
$
|
145.2
|
|
|
N/A
|
|
|
$
|
145.2
|
|
|
|
|
Total indefinite-lived intangible assets
|
$
|
145.2
|
|
|
N/A
|
|
|
$
|
145.2
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total intangible assets
|
$
|
719.3
|
|
|
$
|
(187.3
|
)
|
|
$
|
532.0
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
December 31, 2017
|
||||||||||||
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
Weighted-Average Useful Life (in Years)
|
||||||
Finite-lived intangible assets:
|
|
|
|
|
|
|
|
||||||
Trademarks and licenses
|
$
|
271.4
|
|
|
$
|
(72.8
|
)
|
|
$
|
198.6
|
|
|
13
|
Customer relationships
|
250.6
|
|
|
(46.8
|
)
|
|
203.8
|
|
|
13
|
|||
Patents and internally-developed intellectual property
|
20.8
|
|
|
(8.4
|
)
|
|
12.4
|
|
|
7
|
|||
Distribution rights
|
31.0
|
|
|
(2.3
|
)
|
|
28.7
|
|
|
17
|
|||
Other
|
1.3
|
|
|
(0.6
|
)
|
|
0.7
|
|
|
2
|
|||
Total finite-lived intangible assets
|
$
|
575.1
|
|
|
$
|
(130.9
|
)
|
|
$
|
444.2
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
||||||
Trade names
|
$
|
147.9
|
|
|
N/A
|
|
|
$
|
147.9
|
|
|
|
|
Total indefinite-lived intangible assets
|
$
|
147.9
|
|
|
N/A
|
|
|
$
|
147.9
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Total intangible assets
|
$
|
723.0
|
|
|
$
|
(130.9
|
)
|
|
$
|
592.1
|
|
|
|
|
Estimated Amortization Expense
|
||
2019
|
$
|
41.3
|
|
2020
|
34.1
|
|
|
2021
|
33.1
|
|
|
2022
|
32.2
|
|
|
2023
|
30.7
|
|
|
Thereafter
|
215.4
|
|
|
Total
|
$
|
386.8
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Advertising and promotional costs
|
$
|
76.2
|
|
|
$
|
84.0
|
|
Sales returns and allowances
|
97.7
|
|
|
61.7
|
|
||
Compensation and related benefits
|
55.9
|
|
|
59.6
|
|
||
Taxes
|
30.9
|
|
|
48.4
|
|
||
Restructuring reserve
|
26.4
|
|
|
33.3
|
|
||
Interest
|
33.8
|
|
|
23.8
|
|
||
Other
|
110.0
|
|
|
102.0
|
|
||
Total
|
$
|
430.9
|
|
|
$
|
412.8
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
2018 Foreign Asset-Based Term Loan Credit Agreement due 2021, net of discounts and debt issuance costs (see (a) below)
|
$
|
82.7
|
|
|
$
|
—
|
|
2016 Revolving Credit Facility due 2021, net of debt issuance costs (see (b) below)
|
330.0
|
|
|
152.1
|
|
||
2016 Term Loan Facility: 2016 Term Loan due 2023, net of discounts and debt issuance costs (see (c) below)
|
1,724.6
|
|
|
1,735.9
|
|
||
5.75% Senior Notes due 2021, net of debt issuance costs (see (d) below)
|
496.6
|
|
|
495.1
|
|
||
6.25% Senior Notes due 2024, net of debt issuance costs (see (e) below)
|
441.4
|
|
|
440.3
|
|
||
Spanish Government Loan due 2025
|
0.5
|
|
|
0.5
|
|
||
|
$
|
3,075.8
|
|
|
$
|
2,823.9
|
|
Less current portion
(*)
|
(348.1
|
)
|
|
(170.2
|
)
|
||
|
$
|
2,727.7
|
|
|
$
|
2,653.7
|
|
|
|
|
|
||||
Short-term borrowings
|
$
|
9.3
|
|
|
$
|
12.4
|
|
•
|
incur or guarantee additional indebtedness ("Limitation on Debt");
|
•
|
pay dividends, make repayments on indebtedness that is subordinated in right of payment to the
5.75%
Senior Notes and make other "restricted payments" ("Limitation on Restricted Payments");
|
•
|
make certain investments;
|
•
|
create liens on their assets to secure debt;
|
•
|
enter into transactions with affiliates;
|
•
|
merge, consolidate or amalgamate with another company ("Successor Company");
|
•
|
transfer and sell assets ("Limitation on Asset Sales"); and
|
•
|
permit restrictions on the payment of dividends by Products Corporation’s subsidiaries ("Limitation on Dividends from Subsidiaries").
|
Period
|
|
Optimal Redemption Premium Percentage
|
|
2019
|
|
104.688
|
%
|
2020
|
|
103.125
|
%
|
2021
|
|
101.563
|
%
|
2022 and thereafter
|
|
100.000
|
%
|
|
Commitment
|
|
Aggregate principal amount outstanding at December 31, 2018
|
|
Availability at December 31, 2018
(a)
|
||||||
Tranche A of the 2016 Revolving Credit Facility
|
$
|
400.0
|
|
|
$
|
293.5
|
|
|
$
|
96.4
|
|
Tranche B of the 2016 Revolving Credit Facility
|
41.5
|
|
|
41.5
|
|
|
N/A
|
|
|||
Total Tranche A & B of the 2016 Revolving Credit Facility
(a)
|
$
|
441.5
|
|
|
$
|
335.0
|
|
|
$
|
96.4
|
|
Years Ended December 31,
|
|
Long-Term Debt Maturities
|
|
||
2019
|
|
$
|
353.1
|
|
(a)
|
2020
|
|
18.1
|
|
(b)
|
|
2021
|
|
606.4
|
|
(c)
|
|
2022
|
|
18.1
|
|
(b)
|
|
2023
|
|
1,687.6
|
|
(d)
|
|
Thereafter
|
|
450.0
|
|
(e)
|
|
Total long-term debt
|
|
3,133.3
|
|
|
|
Discounts and deferred finance charges
|
|
(57.5
|
)
|
|
|
Total long-term debt, net of discounts and deferred finance charges
|
|
$
|
3,075.8
|
|
|
(a)
|
Amount consists primarily of
$335 million
in aggregate principal amount of borrowings under the 2016 Revolving Credit Facility outstanding as of December 31, 2018 and the quarterly amortization payments payable in 2019 under the 2016 Term Loan Facility.
|
(b)
|
Amount consists primarily of the quarterly amortization payments described in (a) above payable in 2020.
|
(c)
|
Amount is primarily comprised of the
$500 million
in aggregate principal amount under the
5.75%
Senior Notes, which are scheduled to mature in February 2021 and the U.S. dollar equivalent of the
€77 million
in aggregate principal amount under the 2018 Asset-Based Term Facility, in each case outstanding as of December 31, 2018, and the quarterly amortization payment described in (a) above payable in 2021.
|
(d)
|
Amount consists primarily of the quarterly amortization payments due under the 2016 Term Loan Facility during 2023 and the remaining aggregate principal amount outstanding at December 31, 2018 under the 2016 Term Loan Facility, which is scheduled to mature in September 2023.
|
(e)
|
Amount consists of the
$450 million
aggregate principal amount outstanding at December 31, 2018 under the
6.25%
Senior Notes, which are scheduled to mature in August 2024.
|
•
|
Level 1: Fair valuing the asset or liability using observable inputs, such as quoted prices in active markets for identical assets or liabilities;
|
•
|
Level 2: Fair valuing the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
|
•
|
Level 3: Fair valuing the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.
|
|
December 31, 2017
|
||||||||||||||
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Derivatives:
|
|
|
|
|
|
|
|
||||||||
FX Contracts
(a)
|
$
|
0.6
|
|
|
$
|
—
|
|
|
$
|
0.6
|
|
|
$
|
—
|
|
Total assets at fair value
|
$
|
0.6
|
|
|
$
|
—
|
|
|
$
|
0.6
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Derivatives:
|
|
|
|
|
|
|
|
||||||||
FX Contracts
(a)
|
$
|
1.9
|
|
|
$
|
—
|
|
|
$
|
1.9
|
|
|
$
|
—
|
|
2013 Interest Rate Swap
(b)
|
0.9
|
|
|
—
|
|
|
0.9
|
|
|
—
|
|
||||
Total liabilities at fair value
|
$
|
2.8
|
|
|
$
|
—
|
|
|
$
|
2.8
|
|
|
$
|
—
|
|
|
December 31, 2018
|
||||||||||||||||||
|
Fair Value
|
|
|
||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Carrying Value
|
||||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Long-term debt, including current portion
(a)
|
$
|
—
|
|
|
$
|
2,259.5
|
|
|
$
|
—
|
|
|
$
|
2,259.5
|
|
|
$
|
3,075.8
|
|
|
December 31, 2017
|
||||||||||||||||||
|
Fair Value
|
|
|
||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Carrying Value
|
||||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Long-term debt, including current portion
(a)
|
$
|
—
|
|
|
$
|
2,131.5
|
|
|
$
|
—
|
|
|
$
|
2,131.5
|
|
|
$
|
2,823.9
|
|
|
Fair Values of Derivative Instruments
|
||||||||||||
|
Assets
|
|
Liabilities
|
||||||||||
|
Balance Sheet
|
|
|
December 31,
2017 |
|
Balance Sheet
|
|
|
December 31,
2017 |
||||
|
Classification
|
|
|
Fair Value
|
|
Classification
|
|
|
Fair Value
|
||||
Derivative financial instruments:
|
|
|
|
|
|
|
|
||||||
FX Contracts
(a)
|
Prepaid expenses and other
|
|
|
$
|
0.6
|
|
|
Accrued Expenses and other
|
|
|
$
|
1.9
|
|
2013 Interest Rate Swap
(b)
|
Prepaid expenses and other
|
|
|
—
|
|
|
Accrued expenses and other
|
|
|
0.9
|
|
Derivative Instruments
|
|
Statement of Operations Classification
|
Amount of Gain (Loss) Recognized in Net (Loss) Income
|
|||||||
Year Ended December 31,
|
||||||||||
2018
|
|
2017
|
||||||||
Derivative financial instruments:
|
|
|
|
|||||||
2013 Interest Rate Swap
|
|
Interest Expense
|
$
|
(1.2
|
)
|
|
$
|
(3.7
|
)
|
|
FX Contracts
|
|
Foreign currency gain (loss), net
|
0.2
|
|
|
(4.1
|
)
|
|||
2013 Interest Rate Swap
|
|
Miscellaneous, net
|
0.2
|
|
|
0.1
|
|
|
Amount of Gain Recognized in Other Comprehensive (Loss) Income
|
||||||
Year Ended December 31,
|
|||||||
2018
|
|
2017
|
|||||
Derivatives previously designated as hedging instruments:
|
|
|
|
||||
2013 Interest Rate Swap, net of tax
(a)
|
$
|
0.7
|
|
|
$
|
2.3
|
|
|
Pension Plans
|
|
Other Post-Retirement Benefit Plans
|
||||||||||||
|
December 31,
|
||||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Change in Benefit Obligation:
|
|
|
|
|
|
|
|
||||||||
Benefit obligation - beginning of year
|
$
|
(661.4
|
)
|
|
$
|
(640.5
|
)
|
|
$
|
(14.0
|
)
|
|
$
|
(13.4
|
)
|
Service cost
|
(2.0
|
)
|
|
(3.0
|
)
|
|
—
|
|
|
—
|
|
||||
Interest cost
|
(18.6
|
)
|
|
(19.6
|
)
|
|
(0.4
|
)
|
|
(0.4
|
)
|
||||
Actuarial gain (loss)
|
42.0
|
|
|
(22.3
|
)
|
|
1.4
|
|
|
(1.1
|
)
|
||||
Curtailment gain
|
—
|
|
|
3.3
|
|
|
—
|
|
|
—
|
|
||||
Other pension settlements
|
—
|
|
|
3.6
|
|
|
—
|
|
|
—
|
|
||||
Benefits paid
|
45.2
|
|
|
43.2
|
|
|
0.8
|
|
|
0.9
|
|
||||
Other
(a)
|
—
|
|
|
(18.4
|
)
|
|
—
|
|
|
—
|
|
||||
Plan participant contributions
|
(0.6
|
)
|
|
(0.7
|
)
|
|
—
|
|
|
—
|
|
||||
Foreign currency translation adjustments
|
4.4
|
|
|
(7.0
|
)
|
|
—
|
|
|
—
|
|
||||
Benefit obligation - end of year
|
$
|
(591.0
|
)
|
|
$
|
(661.4
|
)
|
|
$
|
(12.2
|
)
|
|
$
|
(14.0
|
)
|
Change in Plan Assets:
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets - beginning of year
|
$
|
497.2
|
|
|
$
|
464.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Actual return on plan assets
|
(24.2
|
)
|
|
53.5
|
|
|
—
|
|
|
—
|
|
||||
Employer contributions
|
8.0
|
|
|
7.6
|
|
|
0.8
|
|
|
0.9
|
|
||||
Other pension settlements
|
—
|
|
|
(3.6
|
)
|
|
—
|
|
|
—
|
|
||||
Benefits paid
|
(45.2
|
)
|
|
(43.2
|
)
|
|
(0.8
|
)
|
|
(0.9
|
)
|
||||
Other
(a)
|
—
|
|
|
11.6
|
|
|
—
|
|
|
|
|||||
Plan participant contributions
|
0.6
|
|
|
0.7
|
|
|
—
|
|
|
|
|||||
Foreign currency translation adjustments
|
(4.0
|
)
|
|
6.6
|
|
|
—
|
|
|
—
|
|
||||
Fair value of plan assets - end of year
|
$
|
432.4
|
|
|
$
|
497.2
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Unfunded status of plans at December 31,
|
$
|
(158.6
|
)
|
|
$
|
(164.2
|
)
|
|
$
|
(12.2
|
)
|
|
$
|
(14.0
|
)
|
(a)
|
Other includes the addition of a foreign non-qualified defined benefit plan assumed in connection with the Elizabeth Arden Acquisition
.
|
|
Pension Plans
|
|
Other Post-Retirement Benefit Plans
|
||||||||||||
|
December 31,
|
||||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Other long-term assets
|
$
|
4.8
|
|
|
$
|
1.5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||||
Accrued expenses and other
|
(5.9
|
)
|
|
(6.2
|
)
|
|
(0.7
|
)
|
|
(0.7
|
)
|
||||
Pension and other post-retirement benefit liabilities
|
(157.5
|
)
|
|
(159.5
|
)
|
|
(11.5
|
)
|
|
(13.3
|
)
|
||||
Total liability
|
$
|
(158.6
|
)
|
|
$
|
(164.2
|
)
|
|
$
|
(12.2
|
)
|
|
$
|
(14.0
|
)
|
|
|
|
|
|
|
|
|
||||||||
Accumulated other comprehensive loss, gross
|
$
|
252.6
|
|
|
$
|
253.2
|
|
|
$
|
2.7
|
|
|
$
|
4.5
|
|
Income tax benefit
|
(44.4
|
)
|
|
(43.3
|
)
|
|
(0.6
|
)
|
|
(0.9
|
)
|
||||
Portion allocated to Revlon Holdings
|
(0.8
|
)
|
|
(0.9
|
)
|
|
—
|
|
|
(0.2
|
)
|
||||
Accumulated other comprehensive loss, net
|
$
|
207.4
|
|
|
$
|
209.0
|
|
|
$
|
2.1
|
|
|
$
|
3.4
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Projected benefit obligation
|
$
|
591.0
|
|
|
$
|
661.4
|
|
Accumulated benefit obligation
|
589.1
|
|
|
661.1
|
|
||
Fair value of plan assets
|
432.4
|
|
|
497.2
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
Other
Post-Retirement Benefit Plans |
||||||||||||
|
Year Ended December 31,
|
||||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net periodic benefit costs:
|
|
|
|
|
|
|
|
||||||||
Service cost
|
$
|
2.0
|
|
|
$
|
3.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest cost
|
18.6
|
|
|
19.6
|
|
|
0.4
|
|
|
0.4
|
|
||||
Expected return on plan assets
|
(27.8
|
)
|
|
(28.6
|
)
|
|
—
|
|
|
—
|
|
||||
Amortization of actuarial loss
|
9.2
|
|
|
9.5
|
|
|
0.4
|
|
|
0.3
|
|
||||
Curtailment gain
(a)
|
(0.1
|
)
|
|
(2.6
|
)
|
|
—
|
|
|
—
|
|
||||
Total net periodic benefit costs prior to allocation
|
$
|
1.9
|
|
|
$
|
0.9
|
|
|
$
|
0.8
|
|
|
$
|
0.7
|
|
Portion allocated to Revlon Holdings
|
(0.1
|
)
|
|
(0.1
|
)
|
|
—
|
|
|
—
|
|
||||
Total net periodic benefit costs
|
$
|
1.8
|
|
|
$
|
0.8
|
|
|
$
|
0.8
|
|
|
$
|
0.7
|
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
Net periodic benefit (income) costs:
|
|
|
|
||||
Cost of sales
|
$
|
0.1
|
|
|
$
|
—
|
|
Selling, general and administrative expense
|
1.9
|
|
|
3.0
|
|
||
Miscellaneous, net
|
0.6
|
|
|
(1.5
|
)
|
||
Total net periodic benefit costs
(a)
|
$
|
2.6
|
|
|
$
|
1.5
|
|
|
Pension Benefits
|
|
Post-Retirement Benefits
|
|
Total
|
||||||
Net actuarial loss
|
$
|
252.7
|
|
|
$
|
2.7
|
|
|
$
|
255.4
|
|
Prior service cost
|
(0.1
|
)
|
|
—
|
|
|
(0.1
|
)
|
|||
Accumulated Other Comprehensive Loss, Gross
|
252.6
|
|
|
2.7
|
|
|
255.3
|
|
|||
Income tax benefit
|
(44.4
|
)
|
|
(0.6
|
)
|
|
(45.0
|
)
|
|||
Portion allocated to Revlon Holdings
|
(0.8
|
)
|
|
—
|
|
|
(0.8
|
)
|
|||
Accumulated Other Comprehensive Loss, Net
|
$
|
207.4
|
|
|
$
|
2.1
|
|
|
$
|
209.5
|
|
|
U.S. Plans
|
|
International Plans
|
||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
Discount rate
|
4.13
|
%
|
|
3.47
|
%
|
|
2.52
|
%
|
|
2.19
|
%
|
Rate of future compensation increases
|
3.50
|
%
|
|
3.50
|
%
|
|
2.02
|
%
|
|
1.75
|
%
|
|
U.S. Plans
|
|
International Plans
|
||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
Discount rate
|
3.47
|
%
|
|
3.92
|
%
|
|
2.19
|
%
|
|
2.24
|
%
|
Expected long-term return on plan assets
|
6.00
|
%
|
|
6.50
|
%
|
|
4.95
|
%
|
|
4.81
|
%
|
Rate of future compensation increases
|
3.50
|
%
|
|
3.50
|
%
|
|
1.75
|
%
|
|
2.01
|
%
|
|
Target Ranges
|
||
|
U.S. Plans
|
|
International Plans
|
Asset Class:
|
|
|
|
Common and preferred stock
|
0% - 10%
|
|
—
|
Mutual funds
|
20% - 30%
|
|
—
|
Fixed income securities
|
10% - 20%
|
|
—
|
Common and collective funds
|
30% - 50%
|
|
100%
|
Hedge funds
|
5% - 15%
|
|
—
|
Cash and other investments
|
0% - 10%
|
|
—
|
|
U.S. Plans
|
|
International Plans
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Fair value of plan assets
|
$
|
358.3
|
|
|
$
|
413.6
|
|
|
$
|
74.1
|
|
|
$
|
83.6
|
|
•
|
Common and preferred stock: The fair values of the investments included in the common and preferred stock asset class generally reflect the closing price reported on the major market where the individual securities are traded. The Plan classifies common and preferred stock investments within Level 1 of the fair value hierarchy.
|
•
|
Mutual funds: The fair values of the investments included in the mutual funds asset class are determined using net asset value (“NAV”) provided by the administrator of the funds. The NAV is based on the closing price reported on the major market where the individual securities within the mutual fund are traded. The Company classifies mutual fund investments within Level 1 of the fair value hierarchy.
|
•
|
Fixed income securities: The fair values of the investments included in the fixed income securities asset class are based on a compilation of primarily observable market information and/or broker quotes. The Company classifies fixed income securities investments within Level 2 of the fair value hierarchy.
|
•
|
Common and collective funds: The fair values of the investments included in the common and collective funds asset class are determined using NAV provided by the administrator of the funds. The NAV is based on the value of the underlying assets owned by the common and collective fund, minus its liabilities, and then divided by the number of shares outstanding. The redemption frequencies for the investments in the common and collective funds asset class range from daily to monthly, with redemption notice periods that range from 2 to 10 business days. The Company classifies common and collective fund investments within Level 1 or Level 2 of the fair value hierarchy, depending on whether certain criteria are met. Some common and collective funds for which fair value is not readily determinable are recorded using NAV per share or its equivalent, as permitted by the practical expedient, provided by ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset per Share (or Its Equivalent) (the “ASU No. 2015-07 practical expedient”). These investments are not assigned a fair value hierarchy level.
|
•
|
Hedge funds: The hedge funds asset class includes hedge funds that primarily invest in a grouping of equities, fixed income instruments, currencies, derivatives and/or commodities. The fair values of investments included in the hedge
|
•
|
Cash and cash equivalents: Cash and cash equivalents are measured at cost, which approximates fair value. The Company classifies cash and cash equivalents within Level 1 of the fair value hierarchy.
|
|
|
|
Quoted Prices in Active Markets for Identical Assets
|
|
Significant Observable Inputs
|
|
Significant Unobservable Inputs
|
||||||||
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Common and Preferred Stock:
|
|
|
|
|
|
|
|
||||||||
U.S. Small/Mid Cap Equity
|
$
|
7.0
|
|
|
$
|
7.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Mutual Funds
(a)
:
|
|
|
|
|
|
|
|
||||||||
Corporate Bonds
|
10.6
|
|
|
10.6
|
|
|
—
|
|
|
—
|
|
||||
Government Bonds
|
13.4
|
|
|
13.4
|
|
|
—
|
|
|
—
|
|
||||
U.S. Large Cap Equity
|
0.2
|
|
|
0.2
|
|
|
—
|
|
|
—
|
|
||||
International Equities
|
9.4
|
|
|
9.4
|
|
|
—
|
|
|
—
|
|
||||
Emerging Markets International Equity
|
5.3
|
|
|
5.3
|
|
|
—
|
|
|
—
|
|
||||
Cash and Cash Equivalents
|
2.2
|
|
|
2.2
|
|
|
—
|
|
|
—
|
|
||||
Other
(b)
|
1.8
|
|
|
1.8
|
|
|
—
|
|
|
—
|
|
||||
Fixed Income Securities:
|
|
|
|
|
|
|
|
||||||||
Government Bonds
|
70.0
|
|
|
—
|
|
|
70.0
|
|
|
—
|
|
||||
Common and Collective Funds
(a)
:
|
|
|
|
|
|
|
|
||||||||
Corporate Bonds
|
40.7
|
|
|
19.6
|
|
|
21.1
|
|
|
—
|
|
||||
Government Bonds
|
43.0
|
|
|
6.6
|
|
|
36.4
|
|
|
—
|
|
||||
U.S. Large Cap Equity
|
54.5
|
|
|
38.8
|
|
|
15.7
|
|
|
—
|
|
||||
U.S. Small/Mid Cap Equity
|
6.9
|
|
|
6.9
|
|
|
—
|
|
|
—
|
|
||||
International Equities
|
58.4
|
|
|
5.5
|
|
|
52.9
|
|
|
—
|
|
||||
Emerging Markets International Equity
|
14.9
|
|
|
8.5
|
|
|
6.4
|
|
|
—
|
|
||||
Cash and Cash Equivalents
|
1.7
|
|
|
1.7
|
|
|
—
|
|
|
—
|
|
||||
Other
(b)
|
(1.6
|
)
|
|
—
|
|
|
(1.6
|
)
|
|
—
|
|
||||
Cash and Cash Equivalents
|
22.2
|
|
|
22.2
|
|
|
—
|
|
|
—
|
|
||||
Total Plan Assets in the fair value hierarchy
|
$
|
360.6
|
|
|
$
|
159.7
|
|
|
$
|
200.9
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
Investments measured at Net Asset Value
(c)
|
|
|
|
|
|
|
|
||||||||
Common and Collective Funds
|
36.3
|
|
|
|
|
|
|
|
|||||||
Hedge Funds
|
35.5
|
|
|
|
|
|
|
|
|||||||
Total Plan Assets measured at Net Asset Value
|
$
|
71.8
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||||||
Total Plan Assets at Fair Value
|
$
|
432.4
|
|
|
$
|
159.7
|
|
|
$
|
200.9
|
|
|
—
|
|
(a)
|
The investments in mutual funds and common and collective funds are disclosed above within the respective underlying investments’ class (i.e., various equities, corporate bonds, government bonds and other investment classes), while the fair value hierarchy levels of the investments are based on the respective trust’s direct ownership unit of account.
|
(b)
|
Comprised of investments in equities, fixed income instruments, currencies, derivatives and/or commodities.
|
(c)
|
These investments are presented for reconciliation purposes, but are not required to be categorized in the fair value hierarchy as they are measured at fair value using the net asset per share or its equivalent, as permitted by the ASU No. 2015-07 practical expedient.
|
|
|
|
Quoted Prices in Active Markets for Identical Assets
|
|
Significant Observable Inputs
|
|
Significant Unobservable Inputs
|
||||||||
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Common and Preferred Stock:
|
|
|
|
|
|
|
|
||||||||
U.S. Small/Mid Cap Equity
|
$
|
18.3
|
|
|
$
|
18.3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Mutual Funds
(a)
:
|
|
|
|
|
|
|
|
||||||||
Corporate Bonds
|
17.7
|
|
|
17.7
|
|
|
—
|
|
|
—
|
|
||||
Government Bonds
|
8.4
|
|
|
8.4
|
|
|
—
|
|
|
—
|
|
||||
U.S. Large Cap Equity
|
0.1
|
|
|
0.1
|
|
|
—
|
|
|
—
|
|
||||
International Equities
|
3.8
|
|
|
3.8
|
|
|
—
|
|
|
—
|
|
||||
Emerging Markets International Equity
|
7.4
|
|
|
7.4
|
|
|
—
|
|
|
—
|
|
||||
Other
(b)
|
4.5
|
|
|
4.5
|
|
|
—
|
|
|
—
|
|
||||
Fixed Income Securities:
|
|
|
|
|
|
|
|
||||||||
Corporate Bonds
|
46.7
|
|
|
—
|
|
|
46.7
|
|
|
—
|
|
||||
Government Bonds
|
15.4
|
|
|
—
|
|
|
15.4
|
|
|
—
|
|
||||
Common and Collective Funds
(a)(d)
:
|
|
|
|
|
|
|
|
||||||||
Corporate Bonds
|
49.8
|
|
|
27.3
|
|
|
22.5
|
|
|
—
|
|
||||
Government Bonds
|
44.1
|
|
|
7.4
|
|
|
36.7
|
|
|
—
|
|
||||
U.S. Large Cap Equity
|
68.7
|
|
|
55.1
|
|
|
13.6
|
|
|
—
|
|
||||
U.S. Small/Mid Cap Equity
|
16.1
|
|
|
16.1
|
|
|
—
|
|
|
—
|
|
||||
International Equities
|
75.7
|
|
|
5.7
|
|
|
70.0
|
|
|
—
|
|
||||
Emerging Markets International Equity
|
18.3
|
|
|
10.6
|
|
|
7.7
|
|
|
—
|
|
||||
Cash and Cash Equivalents
|
4.2
|
|
|
4.2
|
|
|
—
|
|
|
—
|
|
||||
Other
(b)
|
3.5
|
|
|
0.0
|
|
|
3.5
|
|
|
—
|
|
||||
Cash and Cash Equivalents
|
8.2
|
|
|
8.2
|
|
|
—
|
|
|
—
|
|
||||
Total Plan Assets in the fair value hierarchy
|
$
|
410.9
|
|
|
$
|
194.8
|
|
|
$
|
216.1
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||||
Investments measured at Net Asset Value
(c)
|
|
|
|
|
|
|
|
||||||||
Common and Collective Funds
|
37.5
|
|
|
|
|
|
|
|
|||||||
Hedge Funds
|
48.8
|
|
|
|
|
|
|
|
|||||||
Total Plan Assets measured at Net Asset Value
|
$
|
86.3
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||||||
Total Plan Assets at Fair Value
|
$
|
497.2
|
|
|
$
|
194.8
|
|
|
$
|
216.1
|
|
|
$
|
—
|
|
(a)
|
The investments in mutual funds and common and collective funds are disclosed above within the respective underlying investments’ class (i.e., various equities, corporate bonds, government bonds and other investment classes), while the fair value hierarchy levels of the investments are based on the respective trust’s direct ownership unit of account.
|
(b)
|
Comprised of investments in equities, fixed income instruments, currencies, derivatives and/or commodities.
|
(c)
|
These investments are presented for reconciliation purposes, but are not required to be categorized in the fair value hierarchy as they are measured at fair value using the net asset per share or its equivalent, as permitted by the ASU No. 2015-07 practical expedient.
|
(d)
|
Commencing in 2018, the Company determined that certain of its investments in common and collective funds met certain criteria to be considered Level 2 investments within the fair value hierarchy. As such, the 2017 fair value hierarchy schedule was updated to conform to the current presentation.
|
|
Total Pension Benefits
|
|
Total Other Benefits
|
||||
2019
|
$
|
44.5
|
|
|
$
|
1.2
|
|
2020
|
44.5
|
|
|
1.2
|
|
||
2021
|
42.3
|
|
|
1.2
|
|
||
2022
|
42.6
|
|
|
1.1
|
|
||
2023
|
41.8
|
|
|
1.1
|
|
||
Years 2024 to 2028
|
196.1
|
|
|
4.7
|
|
|
Restricted Stock (000's)
|
|
Weighted Average Grant Date Fair Value Per Share
|
|||
Outstanding at January 1, 2017
|
411.0
|
|
|
$
|
30.78
|
|
Granted
|
853.1
|
|
|
30.94
|
|
|
Vested
(b)
|
(216.0
|
)
|
|
32.63
|
|
|
Forfeited
|
(253.1
|
)
|
|
32.60
|
|
|
Outstanding at December 31, 2017
|
795.0
|
|
|
29.87
|
|
|
Granted
(a)
|
1,303.9
|
|
|
19.39
|
|
|
Vested
(b)
|
(388.7
|
)
|
|
33.04
|
|
|
Forfeited
(a)
|
(303.5
|
)
|
|
25.08
|
|
|
Outstanding at December 31, 2018
|
1,406.7
|
|
|
20.32
|
|
(a)
|
The 2018 grants include
69,767
restricted stock awards and
1,234,116
RSUs, the latter granted pursuant to the Long-Term Incentive Program under the Stock Plan, as discussed below. 2018 forfeited shares include
251,495
restricted stock awards and
52,022
RSUs.
|
(b)
|
Of the amounts that vested during
2018
and
2017
,
167,297
and
89,620
shares, respectively, were withheld by the Company to satisfy certain grantees’ minimum withholding tax requirements, which withheld shares became Revlon treasury stock and are not sold on the open market. (See discussion under "Treasury Stock" in Note
17
, "Stockholders' Deficiency").
|
|
Time-Based LTIP RSUs
(000s)
|
|
Weighted-Average Grant Date Fair Value per RSU
|
|||
LTIP RSUs Granted:
|
|
|
|
|||
2018
|
451.6
|
|
|
$
|
19.12
|
|
2017
|
165.5
|
|
|
19.70
|
|
|
Total Time-Based LTIP RSUs granted
|
617.1
|
|
|
|
||
LTIP RSU's Forfeited:
|
|
|
|
|||
2018
|
(16.9
|
)
|
|
$
|
19.19
|
|
2017
|
(9.1
|
)
|
|
19.70
|
|
|
Total Time-Based LTIP RSUs forfeited
|
(26.0
|
)
|
|
|
||
LTIP Outstanding:
|
|
|
|
|||
2018
|
434.7
|
|
|
$
|
19.11
|
|
2017
|
156.4
|
|
|
19.70
|
|
|
Total Time-Based LTIP RSUs as of December 31, 2018
|
591.1
|
|
|
|
|
Performance-Based LTIP RSUs
(000s)
|
|
Weighted-Average Grant Date Fair Value per RSU
|
|||
LTIP RSUs Granted:
|
|
|
|
|||
2018
|
451.6
|
|
|
$
|
19.12
|
|
2017
|
165.5
|
|
|
19.70
|
|
|
Total Performance-Based LTIP RSUs granted
|
617.1
|
|
|
|
||
LTIP RSUs Forfeited:
|
|
|
|
|||
2018
|
(16.9
|
)
|
|
$
|
19.19
|
|
2017
|
(9.1
|
)
|
|
19.70
|
|
|
Total Performance-Based LTIP RSUs forfeited
|
(26.0
|
)
|
|
|
||
LTIP Outstanding:
|
|
|
|
|||
2018
|
434.7
|
|
|
$
|
19.11
|
|
2017
|
156.4
|
|
|
19.70
|
|
|
Total Performance-Based LTIP RSUs as of December 31, 2018
|
591.1
|
|
|
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
Loss from continuing operations before income taxes:
|
|
|
|
||||
United States
|
$
|
(298.5
|
)
|
|
$
|
(190.7
|
)
|
Foreign
|
6.6
|
|
|
27.2
|
|
||
|
$
|
(291.9
|
)
|
|
$
|
(163.5
|
)
|
Provision for income taxes:
|
|
|
|
||||
United States federal
|
$
|
(27.2
|
)
|
|
$
|
7.0
|
|
State and local
|
(3.6
|
)
|
|
9.0
|
|
||
Foreign
|
33.0
|
|
|
5.8
|
|
||
|
$
|
2.2
|
|
|
$
|
21.8
|
|
Current:
|
|
|
|
||||
United States federal
|
$
|
(8.9
|
)
|
|
$
|
(20.2
|
)
|
State and local
|
(0.8
|
)
|
|
1.9
|
|
||
Foreign
|
10.2
|
|
|
17.5
|
|
||
|
0.5
|
|
|
(0.8
|
)
|
||
Deferred:
|
|
|
|
||||
United States federal
|
$
|
(18.3
|
)
|
|
$
|
27.2
|
|
State and local
|
(2.8
|
)
|
|
7.1
|
|
||
Foreign
|
22.8
|
|
|
(11.7
|
)
|
||
|
$
|
1.7
|
|
|
$
|
22.6
|
|
Total Provision for income taxes
|
$
|
2.2
|
|
|
$
|
21.8
|
|
•
|
The Company reduced the carrying value of its federal deferred tax assets to reflect the reduction from 35% to 21% in the U.S. federal income tax rate and recorded a one-time, non-cash charge of
$47.9 million
, with
$30.3 million
related to deferred balances carried as of January 1, 2017 and the remaining
$17.6 million
related to the deferred activity in the year ended December 31, 2017. No adjustment was made to this provisional amount during 2018.
|
•
|
The Company estimated that it had a net deficit in its non-U.S. earnings subject to the transition tax as of the applicable measurement dates in the year ended December 31, 2017. Therefore, the Company did not record a liability for the transition tax. No adjustment was made to this provisional amount during 2018.
|
•
|
In connection with the Company’s indefinite reinvestment assertion, a tax benefit of
$7.7 million
was recorded to adjust its deferred tax liabilities.
|
•
|
The Company concluded on the policy to record the taxes for the GILTI provision of the Tax Act as a period cost.
|
•
|
The Company concluded on the policy of tax law ordering for reflecting the realization of the net operating losses expected to offset future GILTI.
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
Computed income tax benefit
|
$
|
(61.3
|
)
|
|
$
|
(57.2
|
)
|
State and local taxes, net of U.S. federal income tax benefit
|
(2.9
|
)
|
|
6.1
|
|
||
Foreign and U.S. tax effects attributable to operations outside the U.S.
|
(9.3
|
)
|
|
(6.5
|
)
|
||
Net establishment (release) of valuation allowance
|
75.0
|
|
|
(1.2
|
)
|
||
Net release of uncertain tax positions
|
(4.3
|
)
|
|
(2.8
|
)
|
||
Foreign dividends and earnings taxable in the U.S.
|
12.8
|
|
|
1.8
|
|
||
Impairment for which there is no tax benefit
|
4.3
|
|
|
0.4
|
|
||
Tax effect of basis reclassification
|
—
|
|
|
23.7
|
|
||
Impact of the Tax Act
|
(7.7
|
)
|
|
47.9
|
|
||
Other
|
(4.4
|
)
|
|
9.6
|
|
||
Total provision for income taxes
|
$
|
2.2
|
|
|
$
|
21.8
|
|
|
December 31,
|
||||||
|
2018
|
|
2017
|
||||
Deferred tax assets:
|
|
|
|
||||
Inventories
|
$
|
23.6
|
|
|
$
|
21.2
|
|
Net operating loss carryforwards - U.S.
|
160.8
|
|
|
161.0
|
|
||
Net operating loss carryforwards - foreign
|
69.7
|
|
|
47.0
|
|
||
Disallowed Interest Carryover - U.S.
|
42.8
|
|
|
—
|
|
||
Employee benefits
|
53.6
|
|
|
54.5
|
|
||
Sales-related reserves
|
21.1
|
|
|
19.1
|
|
||
Foreign currency translation adjustment
|
1.1
|
|
|
10.3
|
|
||
Other
|
50.4
|
|
|
67.6
|
|
||
Total gross deferred tax assets
|
423.1
|
|
|
380.7
|
|
||
Less valuation allowance
|
(165.7
|
)
|
|
(90.7
|
)
|
||
Total deferred tax assets, net of valuation allowance
|
257.4
|
|
|
290.0
|
|
||
Deferred tax liabilities:
|
|
|
|
||||
Plant, equipment and other assets
|
(32.6
|
)
|
|
(21.7
|
)
|
||
Intangibles
|
(81.5
|
)
|
|
(95.0
|
)
|
||
Other
|
(12.1
|
)
|
|
(36.0
|
)
|
||
Total gross deferred tax liabilities
|
(126.2
|
)
|
|
(152.7
|
)
|
||
Net deferred tax assets
|
$
|
131.2
|
|
|
$
|
137.3
|
|
|
Tax
|
|
Interest and Penalties
|
|
Total
|
||||||
Balance at January 1, 2017
|
$
|
82.7
|
|
|
$
|
10.6
|
|
|
$
|
93.3
|
|
Increase based on tax positions taken in a prior year
|
9.1
|
|
|
1.5
|
|
|
10.6
|
|
|||
Decrease based on tax positions taken in a prior year
(a)
|
(19.6
|
)
|
|
(1.5
|
)
|
|
(21.1
|
)
|
|||
Increase based on tax positions taken in the current year
|
11.0
|
|
|
0.2
|
|
|
11.2
|
|
|||
Decrease resulting from the lapse of statutes of limitations
|
(7.3
|
)
|
|
(1.8
|
)
|
|
(9.1
|
)
|
|||
Balance at December 31, 2017
|
75.9
|
|
|
9.0
|
|
|
84.9
|
|
|||
Increase based on tax positions taken in a prior year
|
2.8
|
|
|
5.4
|
|
|
8.2
|
|
|||
Decrease based on tax positions taken in a prior year
|
(15.5
|
)
|
|
(3.8
|
)
|
|
(19.3
|
)
|
|||
Increase based on tax positions taken in the current year
|
6.5
|
|
|
0.2
|
|
|
6.7
|
|
|||
Decrease resulting from the lapse of statutes of limitations
|
(4.8
|
)
|
|
(1.0
|
)
|
|
(5.8
|
)
|
|||
Balance at December 31, 2018
|
$
|
64.9
|
|
|
$
|
9.8
|
|
|
$
|
74.7
|
|
(a)
|
Includes a provisional amount for the expected impact of the Tax Act on the Company’s unrecognized tax benefits.
|
|
Foreign Currency Translation
|
|
Actuarial (Loss) Gain on Post-retirement Benefits
|
|
Deferred Gain (Loss) - Hedging
|
|
Other
|
|
Accumulated Other Comprehensive Loss
|
||||||||||
Balance at January 1, 2017
|
$
|
(24.0
|
)
|
|
$
|
(224.4
|
)
|
|
$
|
(3.0
|
)
|
|
$
|
(0.3
|
)
|
|
$
|
(251.7
|
)
|
Foreign currency translation adjustment, net of tax of $0.4 million
|
9.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9.0
|
|
|||||
Amortization of pension related costs, net of tax of $(1.6) million
(a)
|
—
|
|
|
8.1
|
|
|
—
|
|
|
—
|
|
|
8.1
|
|
|||||
Pension re-measurement, net of tax of $0.3 million
|
—
|
|
|
1.8
|
|
|
—
|
|
|
—
|
|
|
1.8
|
|
|||||
Amortization of deferred losses related to the de-designated 2013 Interest Rate Swap, net of tax of $1.4 million
(b)
|
—
|
|
|
—
|
|
|
2.3
|
|
|
—
|
|
|
2.3
|
|
|||||
Curtailment gain, net of tax of $(0.3) million
(d)
|
—
|
|
|
2.1
|
|
|
—
|
|
|
—
|
|
|
2.1
|
|
|||||
Other comprehensive income
|
$
|
9.0
|
|
|
$
|
12.0
|
|
|
$
|
2.3
|
|
|
$
|
—
|
|
|
$
|
23.3
|
|
Balance at December 31, 2017
|
$
|
(15.0
|
)
|
|
$
|
(212.4
|
)
|
|
$
|
(0.7
|
)
|
|
$
|
(0.3
|
)
|
|
$
|
(228.4
|
)
|
Foreign currency translation adjustment, net of tax of $0.1 million
|
(9.4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9.4
|
)
|
|||||
Amortization of pension related costs, net of tax of $(1.0) million
(a)
|
—
|
|
|
8.4
|
|
|
—
|
|
|
—
|
|
|
8.4
|
|
|||||
Pension re-measurement, net of tax of $2.5 million
|
|
|
(5.5
|
)
|
|
|
|
|
|
(5.5
|
)
|
||||||||
Amortization of deferred losses related to the de-designated 2013 Interest Rate Swap, net of tax of $0.5 million
(b)
|
—
|
|
|
—
|
|
|
0.7
|
|
|
—
|
|
|
0.7
|
|
|||||
Other comprehensive (loss) income
|
$
|
(9.4
|
)
|
|
$
|
2.9
|
|
|
$
|
0.7
|
|
|
$
|
—
|
|
|
$
|
(5.8
|
)
|
Balance at December 31, 2018
|
$
|
(24.4
|
)
|
|
$
|
(209.5
|
)
|
|
$
|
—
|
|
|
$
|
(0.3
|
)
|
|
$
|
(234.2
|
)
|
(b)
|
See Note
12
, "Financial Instruments," for further discussion of the 2013 Interest Rate Swap, which expired in May 2018.
|
|
|
|
|
|
2013
Interest Rate Swap
|
||
Beginning accumulated losses at January 1, 2018
|
|
$
|
(0.7
|
)
|
Reclassifications into earnings (net of $0.5 million tax benefit)
(a)
|
|
0.7
|
|
|
Ending accumulated losses at December 31, 2018
|
|
$
|
—
|
|
|
|
|
|
|
2013
Interest Rate Swap
|
||
Beginning accumulated losses at January 1, 2017
|
|
$
|
(3.0
|
)
|
Reclassifications into earnings (net of $1.4 million tax benefit)
(a)
|
|
2.3
|
|
|
Ending accumulated losses at December 31, 2017
|
|
$
|
(0.7
|
)
|
|
Class A Common Stock
|
|
Treasury Stock
|
||
Balance, January 1, 2017
|
53,956,073
|
|
|
1,024,908
|
|
Restricted stock grants
|
853,111
|
|
|
—
|
|
Restricted stock forfeitures
|
(253,084
|
)
|
|
—
|
|
Withholding of restricted stock to satisfy taxes
|
—
|
|
|
89,620
|
|
Balance, December 31, 2017
|
54,556,100
|
|
|
1,114,528
|
|
Restricted stock grants
(a)
|
1,303,883
|
|
|
—
|
|
Restricted stock forfeitures
(b)
|
(303,517
|
)
|
|
251,495
|
|
Withholding of restricted stock to satisfy taxes
|
—
|
|
|
167,297
|
|
Balance, December 31, 2018
|
55,556,466
|
|
|
1,533,320
|
|
•
|
Revlon
- The Revlon segment is comprised of the Company's flagship Revlon brands. Revlon segment products are primarily marketed, distributed and sold in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores in the U.S. and internationally under brands such as
Revlon
in color cosmetics;
Revlon ColorSilk
and
Revlon Professional
in hair color; and
Revlon
in beauty tools.
|
•
|
Elizabeth Arden
- The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally, under brands such as
Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference
and
Skin Illuminating
in the Elizabeth Arden skin care brands; and
Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue
and
Elizabeth Arden Green Tea
in Elizabeth Arden fragrances.
|
•
|
Portfolio
- The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as
Almay
and
SinfulColors
in color cosmetics;
American Crew
in men's grooming products (which are also sold direct-to-consumer on its americancrew.com website);
CND
in nail polishes, gel nail color and nail enhancements;
Cutex
nail care products;
Pure Ice
in nail polishes; and
Mitchum
in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of
Creme of Nature
hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a body care line under the
Natural Honey
brand and hair color line under the
Llongueras
brand (licensed from a third party) that are both sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.
|
•
|
Fragrances
- The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as
Juicy Couture
(which are also sold direct-to-consumer on its juicycouturebeauty.com website),
Britney Spears
,
Elizabeth Taylor
,
Curve, John Varvatos
,
Christina Aguilera
,
Giorgio Beverly Hills
,
Ed Hardy
,
Charlie
,
Lucky Brand
,
Paul Sebastian
,
Alfred Sung
,
Jennifer Aniston
,
Mariah Carey
,
Halston
,
Geoffrey Beene
,
La Perla
,
White Shoulders
,
AllSaints
and
Wildfox
.
|
|
Year Ended December 31,
|
||||||
|
2018
|
|
2017
|
||||
Segment Net Sales:
|
|
|
|
||||
Revlon
|
$
|
998.3
|
|
|
$
|
1,089.3
|
|
Elizabeth Arden
|
490.2
|
|
|
433.8
|
|
||
Portfolio
|
564.6
|
|
|
592.5
|
|
||
Fragrances
|
511.4
|
|
|
578.1
|
|
||
Total
|
$
|
2,564.5
|
|
|
$
|
2,693.7
|
|
|
|
|
|
||||
Segment Profit:
|
|
|
|
||||
Revlon
|
$
|
129.6
|
|
|
$
|
180.1
|
|
Elizabeth Arden
|
24.4
|
|
|
6.9
|
|
||
Portfolio
|
7.9
|
|
|
8.1
|
|
||
Fragrances
|
76.0
|
|
|
62.2
|
|
||
Total
|
$
|
237.9
|
|
|
$
|
257.3
|
|
|
|
|
|
||||
Reconciliation:
|
|
|
|
||||
Total Segment Profit
|
$
|
237.9
|
|
|
$
|
257.3
|
|
Less:
|
|
|
|
||||
Depreciation and amortization
|
177.2
|
|
|
155.8
|
|
||
Non-cash stock compensation expense
|
17.2
|
|
|
6.8
|
|
||
Non-Operating items:
|
|
|
|
|
|||
Restructuring and related charges
|
23.1
|
|
|
34.5
|
|
||
Acquisition and integration costs
|
13.9
|
|
|
52.9
|
|
||
Loss on disposal of minority investment
|
20.1
|
|
|
—
|
|
||
Oxford SAP disruption-related charges
|
53.6
|
|
|
—
|
|
||
Elizabeth Arden 2016 Business Transformation Program
|
—
|
|
|
1.1
|
|
||
Elizabeth Arden inventory purchase accounting adjustment, cost of sales
|
—
|
|
|
17.2
|
|
||
Impairment charge
|
18.0
|
|
|
10.8
|
|
||
Deferred compensation
|
—
|
|
|
2.0
|
|
||
Operating loss
|
(85.2
|
)
|
|
(23.8
|
)
|
||
Less:
|
|
|
|
||||
Interest Expense
|
176.6
|
|
|
149.8
|
|
||
Amortization of debt issuance costs
|
13.0
|
|
|
9.1
|
|
||
Foreign currency losses (gains), net
|
15.8
|
|
|
(18.5
|
)
|
||
Miscellaneous, net
|
1.3
|
|
|
(0.7
|
)
|
||
Loss from continuing operations before income taxes
|
$
|
(291.9
|
)
|
|
$
|
(163.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
Year Ended December 31, 2018
|
||||||||||||||||||
|
|
Revlon
|
|
Elizabeth Arden
|
|
Portfolio
|
|
Fragrances
|
|
Total
|
||||||||||
Geographic Area:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net Sales
|
|
|
|
|
|
|
|
|
|
|
||||||||||
North America
|
|
$
|
522.3
|
|
|
$
|
135.6
|
|
|
$
|
350.4
|
|
|
$
|
345.9
|
|
|
$
|
1,354.2
|
|
EMEA*
|
|
226.0
|
|
|
201.0
|
|
|
170.6
|
|
|
120.0
|
|
|
717.6
|
|
|||||
Asia
|
|
105.1
|
|
|
119.5
|
|
|
4.0
|
|
|
12.9
|
|
|
241.5
|
|
|||||
Latin America*
|
|
70.5
|
|
|
11.4
|
|
|
25.7
|
|
|
15.6
|
|
|
123.2
|
|
|||||
Pacific*
|
|
74.4
|
|
|
22.7
|
|
|
13.9
|
|
|
17.0
|
|
|
128.0
|
|
|||||
|
|
$
|
998.3
|
|
|
$
|
490.2
|
|
|
$
|
564.6
|
|
|
$
|
511.4
|
|
|
$
|
2,564.5
|
|
|
|
|
||||||||||||||||||
|
|
Year Ended December 31, 2017
|
||||||||||||||||||
|
|
Revlon
|
|
Elizabeth Arden
|
|
Portfolio
|
|
Fragrances
|
|
Total
|
||||||||||
Geographic Area:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net Sales
|
|
|
|
|
|
|
|
|
|
|
||||||||||
North America
|
|
$
|
581.7
|
|
|
$
|
136.5
|
|
|
$
|
337.9
|
|
|
$
|
377.2
|
|
|
$
|
1,433.3
|
|
EMEA*
|
|
227.4
|
|
|
175.5
|
|
|
198.2
|
|
|
152.5
|
|
|
753.6
|
|
|||||
Asia
|
|
108.7
|
|
|
88.5
|
|
|
9.4
|
|
|
12.9
|
|
|
219.5
|
|
|||||
Latin America*
|
|
87.7
|
|
|
10.2
|
|
|
32.9
|
|
|
16.6
|
|
|
147.4
|
|
|||||
Pacific*
|
|
83.8
|
|
|
23.1
|
|
|
14.1
|
|
|
18.9
|
|
|
139.9
|
|
|||||
|
|
$
|
1,089.3
|
|
|
$
|
433.8
|
|
|
$
|
592.5
|
|
|
$
|
578.1
|
|
|
$
|
2,693.7
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
||||||||||
|
2018
|
|
2017
|
||||||||
Classes of similar products:
|
|
|
|
|
|
|
|
||||
Net sales:
|
|
|
|
|
|
|
|
||||
Color cosmetics
|
$
|
848.7
|
|
|
33%
|
|
$
|
955.3
|
|
|
35%
|
Fragrance
|
679.2
|
|
|
26%
|
|
731.3
|
|
|
27%
|
||
Hair care
|
529.3
|
|
|
21%
|
|
517.3
|
|
|
19%
|
||
Beauty care
|
200.4
|
|
|
8%
|
|
262.4
|
|
|
10%
|
||
Skin care
|
306.9
|
|
|
12%
|
|
227.4
|
|
|
8%
|
||
|
$
|
2,564.5
|
|
|
|
|
$
|
2,693.7
|
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||
Long-lived assets, net:
|
|
|
|
|
|
|
|
||||
United States
|
$
|
1,416.2
|
|
|
84%
|
|
$
|
1,480.1
|
|
|
83%
|
International
|
275.0
|
|
|
16%
|
|
295.6
|
|
|
17%
|
||
|
$
|
1,691.2
|
|
|
|
$
|
1,775.7
|
|
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Numerator:
|
|
|
|
|
||||
Loss from continuing operations, net of taxes
|
|
$
|
(294.1
|
)
|
|
$
|
(185.3
|
)
|
(Loss) income from discontinued operations, net of taxes
|
|
(0.1
|
)
|
|
2.1
|
|
||
Net loss
|
|
$
|
(294.2
|
)
|
|
$
|
(183.2
|
)
|
Denominator:
|
|
|
|
|
||||
Weighted-average common shares outstanding – Basic
|
|
52,797,686
|
|
|
52,597,582
|
|
||
Effect of dilutive restricted stock
|
|
—
|
|
|
—
|
|
||
Weighted-average common shares outstanding – Diluted
|
|
52,797,686
|
|
|
52,597,582
|
|
||
Basic (loss) earnings per common share:
|
|
|
|
|
||||
Continuing operations
|
|
$
|
(5.57
|
)
|
|
$
|
(3.52
|
)
|
Discontinued operations
|
|
—
|
|
|
0.04
|
|
||
Net loss per common share
|
|
$
|
(5.57
|
)
|
|
$
|
(3.48
|
)
|
Diluted (loss) earnings per common share:
|
|
|
|
|
||||
Continuing operations
|
|
$
|
(5.57
|
)
|
|
$
|
(3.52
|
)
|
Discontinued operations
|
|
—
|
|
|
0.04
|
|
||
Net loss per common share
|
|
$
|
(5.57
|
)
|
|
$
|
(3.48
|
)
|
|
|
|
|
|
||||
Unvested restricted stock and RSUs under the Stock Plan
(a)
|
|
272,298
|
|
|
20,804
|
|
(a)
|
These are outstanding common stock equivalents that were not included in the computation of diluted earnings per common share because their inclusion would have had an anti-dilutive effect.
|
Minimum Rental Commitments
|
|
Total
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
||||||||||||||
Capital leases
|
|
$
|
2.6
|
|
|
$
|
1.1
|
|
|
$
|
0.6
|
|
|
$
|
0.3
|
|
|
$
|
0.2
|
|
|
$
|
0.2
|
|
|
$
|
0.2
|
|
Operating leases
|
|
204.7
|
|
|
42.5
|
|
|
33.8
|
|
|
29.8
|
|
|
22.6
|
|
|
18.5
|
|
|
57.5
|
|
Revlon, Inc.
|
|
|||||
(Registrant)
|
|
|||||
|
|
|
|
|
|
|
By: /s/ Debra Perelman
|
|
By: /s/ Victoria Dolan
|
|
By: /s/ Pamela Bucher
|
|
|
Debra Perelman
|
|
Victoria Dolan
|
|
Pamela Bucher
|
|
|
President, Chief Executive Officer &
|
|
Chief Financial Officer
|
|
Vice President,
|
|
|
Director
|
|
|
|
Chief Accounting Officer
|
|
|
|
|
|
|
& Controller
|
|
|
Signature
|
|
Title
|
|
|
|
*
|
|
Chairman of the Board and Director
|
(Ronald O. Perelman)
|
|
|
*
|
|
Vice Chairman of the Board and Director
|
(E. Scott Beattie)
|
|
|
*
|
|
Director
|
(Alan S. Bernikow)
|
|
|
*
|
|
Director
|
(Kristin Dolan)
|
|
|
*
|
|
Director
|
(Robert K. Kretzman)
|
|
|
*
|
|
Director
|
(Ceci Kurzman)
|
|
|
*
|
|
Director
|
(Paul Savas)
|
|
|
*
|
|
Director
|
(Barry F. Schwartz)
|
|
|
*
|
|
Director
|
(Jonathan Schwartz)
|
|
|
*
|
|
Director
|
(Cristiana Falcone Sorrell)
|
|
|
By: /s/ Mitra Hormozi
|
Mitra Hormozi
|
Attorney-in-fact
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Mr. Nichols has been a Director of the Company since June 2019 and has been a member of the Company’s Audit Committee since July 2020. Mr. Nichols is currently an investor and strategic advisor, and the sole Manager operating under Ferrington Green Associates, LLC. Mr. Nichols served as an independent Advisor to Vericast from June 2019 to March 2020. Vericast is a portfolio of companies optimizing customer relationships through a broad variety of omnichannel solutions and is a wholly-owned subsidiary of MacAndrews & Forbes. Mr. Nichols served as a member of the Board of Directors of Vericast from January 2017 to June 2019, served as its Chief Executive Officer from January 2017 until December 2018 and served as its Chairman from January 2019 to June 2019. Mr. Nichols served as Chief Executive Officer of Valassis Communications, Inc., a wholly-owned subsidiary of Vericast, from April 2015 through December 2016. He served as Chief Executive Officer for North America at Experian plc from January 2010 through March 2014, as well as Managing Director for the U.K. and EMEA at Experian from February 2008 until January 2010. Mr. Nichols also led the Experian Internet businesses from February 2007 until February 2008. Prior to that, Mr. Nichols served as Chief Information Officer for Wells Fargo & Company, as Chief Executive Officer of Vicor, Inc., as President of Safeguard Business Systems Inc., as well as having served in various senior leadership positions at Bank of America Corporation. Mr. Nichols also served as Chairman of the Board of Directors of Crystal Cove Conservancy from 2014 to 2017. In addition, Mr. Nichols is a past member of the Economics Leadership Council, University of California, San Diego and served on the Leadership Council for UCI Bren School of Information and Computer Sciences and on the Dean's Advisory Board, University of California, Irvine Merage School. Mr. Nichols also currently serves on the Board of Make-A-Wish International. | |||
For Mr. Beattie, the amount shown under the “All Other Compensation” column reflects fees received by Mr. Beattie in respect of 2021 for advisory services to the Company, pursuant to the terms of an Amended and Restated Consulting Agreement dated March 11, 2020 (the “ Beattie 2020 Consulting Agreement ”), pursuant to which Mr. Beattie agreed to serve as Senior Advisor to the Company’s CEO for a fee of $250,000 per year (the “ Annual Advisory Fee ”), supplemental to the Board’s compensation program for non-employee Directors. On March 10, 2021, the Company and Mr. Beattie entered into an Amendment to the Beattie 2020 Consulting Agreement, effective April 1, 2021 (the “ Amended Beattie Agreement ”), pursuant to which he agreed to continue to provide advisory services to the Company until April 1, 2022. As compensation for Mr. Beattie’s advisory services during the term of the Amended Beattie Agreement, and in lieu of cash compensation, the Company agreed to grant him RSUs equivalent in value to the Annual Advisory Fee, subject to vesting over 12 months, plus an additional true-up of RSUs (“ True-Up RSUs ”) in the event his original RSU grant does not have an aggregate value on the applicable vesting dates equal to the Annual Advisory Fee. The grant date value of this RSU award is included in this column, as determined in accordance with FASB ASC Topic 718. For a discussion of valuation assumptions, see Note 12, "Stock Compensation Plan" to the Company's Audited Consolidated Financial Statements in the Company's 2021 Form 10-K. | |||
Ms. Perelman has served as the Company’s President and Chief Executive Officer since May 2018, as a Director of the Company since June 2015 and as a Director of Products Corporation since May 2018. Ms. Perelman served as a member of the Company’s Compensation Committee until January 2018. Prior to her appointment as CEO, Ms. Perelman served as the Company’s Chief Operating Officer from January 2018 until May 2018. She also served as the Company’s EVP Strategy, Digital Content and New Business Development from December 2017 until January 2018 under a secondment arrangement with MacAndrews & Forbes. From 2014 until December 2017, Ms. Perelman also served as Executive Vice President, Strategy and New Business Development of MacAndrews & Forbes, a diversified holding company. Ms. Perelman joined MacAndrews & Forbes in 2004 as Vice President. Prior to joining MacAndrews & Forbes, Ms. Perelman held various positions at the Company in corporate finance and brand marketing. Ms. Perelman is also the co-founder and serves a member of the Board of Child Mind Institute, serves as a member of the Board of Overseers at Columbia Business School and the Executive Committee for the Partnership for New York City. Ms. Perelman also serves on Mastercard’s CPG Innovate Steering Committee and on the Advisory Board of BrainTrust Founders Studio. | |||
Ms. Dolan has served as a Director of the Company since May 2017 and has served as a member of the Company’s Audit Committee since July 2020. She also has served since November 2016 as Founder and Chief Executive Officer of 605, LLC, as well as Founder and Managing Partner of Dolan Family Ventures. Prior to that, Ms. Dolan held several executive roles at Cablevision Systems Corporation, including as Chief Operating Officer from 2014 until its sale in 2016; President of Optimum Services from 2013 until 2014; Senior Executive Vice President of Product Management and Marketing from 2011 until 2013; and Senior Vice President from 2003 until 2011. Ms. Dolan has served as a member of the Board of Madison Square Garden Entertainment Corp. (“ MSGE ”) since April 2020; AMC Networks Inc. since 2011; and The Wendy’s Company since July 2017. Ms. Dolan previously served as a member of the Board of Directors of Madison Square Garden Sports Corp. from 2015 until December 2021 and MSG Networks from 2018 until the merger with MSGE in July 2021. From 2010 until its sale in 2016, Ms. Dolan served as a member of the Board of Directors of Cablevision. Ms. Dolan previously served on the Foundation Board for SUNY Albany and the National Board for Women in Cable & Telecommunications. | |||
Ms. Perelman has served as the Company’s President and Chief Executive Officer since May 2018, as a Director of the Company since June 2015 and as a Director of Products Corporation since May 2018. Ms. Perelman served as a member of the Company’s Compensation Committee until January 2018. Prior to her appointment as CEO, Ms. Perelman served as the Company’s Chief Operating Officer from January 2018 until May 2018. She also served as the Company’s EVP Strategy, Digital Content and New Business Development from December 2017 until January 2018 under a secondment arrangement with MacAndrews & Forbes. From 2014 until December 2017, Ms. Perelman also served as Executive Vice President, Strategy and New Business Development of MacAndrews & Forbes, a diversified holding company. Ms. Perelman joined MacAndrews & Forbes in 2004 as Vice President. Prior to joining MacAndrews & Forbes, Ms. Perelman held various positions at the Company in corporate finance and brand marketing. Ms. Perelman is also the co-founder and serves a member of the Board of Child Mind Institute, serves as a member of the Board of Overseers at Columbia Business School and the Executive Committee for the Partnership for New York City. Ms. Perelman also serves on Mastercard’s CPG Innovate Steering Committee and on the Advisory Board of BrainTrust Founders Studio. | |||
Ms. Falcone has served as a Director of the Company since March 2014. Since January 2020, Ms. Falcone has served as a strategic adviser and philanthropist investor to a range of companies. From 2018 to 2019 she served as Principal Adviser, Media Affairs at the World Economic Forum (“ WEF ”), having previously served as Senior Adviser to the Chairman at the WEF, a position she has held since 2009. She currently serves as the CEO of the JMCMRJ Foundation. Since April 2021, Ms. Falcone has served as a member of the Board of Directors of SVF Investment Corp 3, and has served as a member of its Audit, Compensation and Nominating Committees. Since February 2021, Ms. Falcone has served as a member of the Board of Directors of Telecom Italia SPA and has served as a member of its Related Party Committee and Sustainability Committee. Since 2013 and until Viacom, Inc. merged with CBS Corporation in December 2019 to form ViacomCBS, Inc., Ms. Falcone served as a member of the Board of Viacom and served as a member of its Governance and Nominating Committee from 2016 until such merger. Ms. Falcone formerly served as Principal Consultant for the Office of Outreach and Partnership for the Inter-American Development Bank from 2011 to 2015. Prior to joining the WEF in 2004, Ms. Falcone held positions at the International Labor Organization from 2002 to 2004 and Shell London Ltd. from 2001 to 2002. Ms. Falcone serves on the Board of Internews and of Global Fashion Agenda, the board of advisors for the Friedman School of Nutrition Science and Policy at Tufts University and as a member of the Board of Trustees at the Paley Center for Media. | |||
Ms. Kurzman has been a Company Director since February 2013 and a Director of Products Corporation since June 2019, and serves as a member of the Company’s Audit Committee and Compensation Committee. Ms. Kurzman serves as President of Nexus Management Group, Inc. (“ Nexus ”), a talent representation, consulting and private investing group focused on 360-degree marketing and asset-building strategies, which she founded in 2004. Prior to founding Nexus, Ms. Kurzman joined Epic/Sony Music in 1997 as Vice President of Worldwide Marketing and held positions of increasing responsibility there until 2004. From 1992 to 1997, Ms. Kurzman held positions of increasing responsibility at Arista Records, including serving as Director of Artist Development. Since October 2020, Ms. Kurzman has served on the Board of Warner Music Group and has served as a member of its Nominating and Corporate Governance Committee. Ms. Kurzman also serves as a member of the Board of Choate Rosemary Hall, the Barefoot Foundation, Migreat Ltd., Tortoise Media Ltd., and Man Group plc., a company listed and traded on the London Stock Exchange. Ms. Kurzman has also served as a member of the Board of Medecins du Monde, Cirque du Soleil Entertainment Group of Spring Studios, the Desmond Tutu Peace Foundation and the Women’s Forum of New York. | |||
Mr. Schwartz has been a Director of the Company since November 2007 and a Director of Products Corporation since March 2004. Mr. Schwartz has served as Emeritus Vice Chairman of MacAndrews & Forbes since July 2019 and prior to that Mr. Schwartz was Executive Vice Chairman and Chief Administrative Officer of MacAndrews & Forbes and various affiliates from October 2007 to December 2015. Prior to that, Mr. Schwartz was Executive Vice President and General Counsel of MacAndrews & Forbes and various affiliates since 1993 and Senior Vice President of MacAndrews & Forbes and various affiliates from 1989 to 1993. Mr. Schwartz has served as a member of the Board of Directors of Scientific Games from 2003 until September 2020, where he served as a member of the Compliance Committee and Compensation Committee; and as a member of the Board of Directors of Gaming and Leisure Properties, Inc. since May 2017, where he currently serves as a member of the Audit and Compliance Committee. Mr. Schwartz was formerly Vice Chairman and has served as a member of the Board of Trustees of The City University of New York until 2020. He is Trustee Emeritus and former Chairman of the Board of Trustees at Kenyon College and is a member of the Georgetown University Law Center Board of Visitors. Mr. Schwartz is a member of the Board of Directors of NYU Langone Medical Center and Jazz at Lincoln Center. | |||
Mr. Bernikow has been a Director of the Company and of Products Corporation since September 2003 and serves as Chairman of the Company’s Audit Committee and as Chairman of the Company’s Compensation Committee. From 1998 until his retirement in May 2003, Mr. Bernikow served as the Deputy Chief Executive Officer of Deloitte & Touche LLP (“ D&T ”). Prior to that, Mr. Bernikow held various senior executive positions at D&T and its predecessor, Touche Ross, which he joined in 1977. Prior to that, Mr. Bernikow was the National Administrative Partner in Charge for the accounting firm, J.K. Lasser & Company, which he joined in 1966. From 2004 until June 2020, Mr. Bernikow served as a member of the Board and as Chairman of the Audit Committee of Mack-Cali Realty Corporation (“ Mack-Cali ”), a publicly-traded company which is required to file reports pursuant to the Exchange Act, and served as its Lead Independent Director since 2014. Mr. Bernikow is currently a member of the Board of K2 Integrity. Mr. Bernikow is also Chairman of the Board and serves as Chairman of the audit committees of certain funds (the “ UBS Funds ”) for which UBS Global Asset Management (US) Inc., a wholly-owned subsidiary of UBS AG, or one of its affiliates serves as investment advisor, sub-advisor or manager. From 2003 until March 2017, Mr. Bernikow served as a member of the Board and as a member of the Nominating and Corporate Governance Committee of Destination XL Group, Inc. Mr. Bernikow also served as the Chairman of the Audit Committee, and as a member of the Nominating and Governance Committee, the Compensation Committee and the Asset/Liability Committee of FCB Financial Holdings, Inc. from 2010 until its merger into Synovus Financial Corporation in January 2019. |
|
Name and Principal Position
|
| |
Year
|
| |
Salary
($)
|
| |
Bonus
($)
|
| |
Stock
Awards
($)
|
| |
Non-Equity
Incentive
Plan
Compensation
($)
|
| |
Change in
Pension Value
and
Nonqualified
Deferred
Compensation
Earnings
($)
|
| |
All Other
Compensation
($)
|
| |
Total
($)
|
|
|
|
| ||||||||||||||||||||||||
|
Debra Perelman
President & CEO
|
| |
2021
|
| |
1,158,942
|
| |
—
|
| |
5,450,000
|
| |
—
|
| |
—
|
| |
168,998
|
| |
6,777,940
|
|
|
2020
|
| |
936,779
|
| |
693,309
|
| |
4,750,000
|
| |
—
|
| |
—
|
| |
84,184
|
| |
6,464,272
|
| |||
|
|
| ||||||||||||||||||||||||
|
Victoria Dolan
CFO
|
| |
2021
|
| |
690,708
|
| |
—
|
| |
1,500,000
|
| |
—
|
| |
—
|
| |
72,451
|
| |
2,263,159
|
|
|
2020
|
| |
547,200
|
| |
288,417
|
| |
500,000
|
| |
—
|
| |
—
|
| |
39,489
|
| |
1,375,106
|
|
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Perelman Debra Golding | - | 426,542 | 0 |